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 CHAPTER 1
Prognostic markers for developmental 
outcomes in children with spinal 
dysraphism
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General introduction
Spinal dysraphism is a relatively common congenital malformation of the central 
nervous system with a prevalence of 1 to 10 in 1,000 live births worldwide [1,2,3]. 
At the same time, it is often considered one of the most complex birth defects 
compatible with long-term survival [4]. Spinal dysraphism is caused by the inad-
equate closure of the neural tube in the developing embryo between 21 to 28 
days of embryonic development, and is generally associated with anatomical and 
functional abnormalities of the brainstem, cerebellum, and cerebral hemispheres. 
Together, these central nervous system malformations lead to complex physical 
and neuropsychological morbidity with serious and life-long impact on daily activi-
ties and community participation of affected individuals [5,6]. Children with spinal 
dysraphism have to face different physical disabilities, for example motor and 
sensory disturbances of the lower limbs; bowel, bladder, and sexual dysfunctions; 
skeletal deformations; hydrocephalus; and symptoms of Chiari II malformation.
Definition of spinal dysraphism
Spinal dysraphism, also called spina bifida or myelomeningocele, can be catego-
rized into open spinal dysraphism and closed spinal dysraphism [7]. In case of open 
spinal dysraphism, the abnormal neural tissue protrudes through open vertebral 
arches, muscle, and a skin defect. Consequently, the neural tissue is exposed to the 
environment without skin covering, although the meninges may still be present. 
In closed spinal dysraphism, abnormal neural tissue is covered by skin, often in 
combination with a subcutaneous lipomatous mass. 
Epidemiology
Spinal dysraphism is part of the broad spectrum of neural tube defects, also includ-
ing anencephaly and encephalocele, which occur less frequently,  The prevalence 
rate of neural tube defects is affected by ethnic, geographic, and dietary factors. 
Neural tube defects occur in approximately one per thousand pregnancies in 
Europe [2]. Worldwide, however, the estimated prevalence rates vary between 1 
and 20 per 1,000 births. The highest neural tube defect prevalence rates were 
published for the rural Northern parts of China at 29.7 per 10,000 births (2006-
2008) [8] and Mongolia at 20.1 per 10,000 births (2005-2008) [9], whereas the 
latest published prevalence rate in the Netherlands was 9.27 per 10,000 births in 
2012 [2,10].
After several studies pointing in that direction, the Medical Research Council 
Vitamin Study results confirmed in 1991 that the majority of neural tube defects 
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could be prevented by maternal folic acid supplement use prior to conception 
and during the first trimester of pregnancy [11]. However, many women do not 
take folic acid supplements prior to conception. In the USA, Canada, and Chile, 
the relative failure of periconceptional folic acid supplementation policies led to 
mandatory fortification of flour with folic acid. Studies following the fortification 
of flour showed a further decline in the neural tube defects rates to approximately 
5.0 per 10,000 live births in those countries [12,13,14]. In many more countries, 
however, the introduction of prenatal ultrasound screening programs for pregnant 
women led to an impressive decrease of the birth prevalence of neural tube de-
fects over the last 25 years. The percentage of cases with open spinal dysraphism 
that were diagnosed before the 24th week of pregnancy increased significantly in 
the Netherlands for the period 2008-2012, from 43% before to 88% after intro-
duction of the mid-pregnancy scan. Subsequently, most of these pregnancies are 
terminated (79%) [15]. These numbers are the same for European countries, such 
as Germany, Belgium, Spain and Italy. For Ireland, no terminations of pregnancies 
in cases with prenatally diagnosed spinal dysraphism were reported in the period 
2010-2014, most likely because of the Catholic religious background. 
Prenatal life – Detection of spinal dysraphism
First trimester screening for nuchal translucency was introduced in the Nether-
lands in the 1990s. This first prenatal test offers early information about a baby’s 
risk of certain chromosomal conditions, namely Down syndrome (trisomy 21) and 
extra sequences of chromosome 18 (trisomy 18) and chromosome 13 (trisomy 
13). [16]. First trimester combined-test screening, a combination of a blood test 
to measure levels of two pregnancy-specific proteins in the mother’s blood and 
an ultrasound exam for nuchal translucency, for Down syndrome, trisomy 13 and 
18, was started in the second half of 2002 on request of the Dutch Health Care 
Inspectorate [17]. Since January 2007, every pregnant woman in The Netherlands 
is also offered a standard 20-week ultrasound scan. The primary aim of this second 
trimester structural ultrasound scan is the detection of neural tube defects. In ad-
dition to the spinal defect itself, scalloping of the frontal bones (the so called lemon 
sign) and a banana-shaped cerebellum due to Chiari malformation are well-known 
foetal cranial features of spinal dysraphism, which can be recognized especially in 
the second trimester [18,19]. Nowadays, ultrasound is the non-invasive screen-
ing modality of choice for the detection of foetal anomalies including neural tube 
defects because of its safety, cost efficiency and detection sensitivity. Of all cases 
with open spinal dysraphism for which a mid-gestational scan was performed in 
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the period 2008-2012, 94% were diagnosed before 24 weeks of gestation, which is 
the legal limit for termination of pregnancy in The Netherlands.  [10].
Prenatal life – Counselling and ultrasound imaging in relation to 
prognosis
Despite the decreasing prevalence of neural tube defects, counselling expectant 
couples carrying foetuses with neural tube defects has become an increasing 
proportion of the clinical practice of perinatologists and paediatric neurologists 
since the introduction of prenatal screening programs. The decision to terminate a 
pregnancy or carry it to term and provide care for a child with a neural tube defect 
is complex and very private. Therefore, it is critically important to provide the 
parents with accurate information, so that they can make as informed a decision 
as possible regarding the termination or continuation of pregnancy. Nowadays, the 
consideration of prenatal surgery (see below for separate discussion) is also in-
cluded in the decision process. In addition to clinical information, prenatal counsel-
ling involves many interacting influences, including: 1) cultural beliefs; 2) religion; 
3) current treatment technology; 4) available resources; and 5) public policy [20].
The now affordable high-resolution ultrasound scan with state-of-the-art equip-
ment allows us to make a very accurate diagnosis of open spinal dysraphisms, 
including detailed information on the entire foetal central nervous system. 
Ultrasound can accurately localize the site of the osseous defects, the largest 
interpeduncular distance, and the type of lesion [18,19,21]. Additional findings 
of kyphosis, scoliosis, or an otherwise anomalous spine, as well as associated 
conditions, such as syringomyelia or club feet can also be identified. The state of 
intracranial comorbidity, including the presence or absence of ventriculomegaly, 
dysgenesis of the corpus callosum, and abnormal hindbrain anatomy (including 
herniation of the cerebellar tonsils), can be recorded in detail. 
Despite all of these technical advances, the prognostic values of the sonographic 
features of an affected foetus with a neural tube defect are still largely unknown. 
As a result, doctors and parents have to decide whether to continue or terminate 
the pregnancy based on limited data. Although the overall outcome of children 
with a spinal dysraphism has improved over the past decades with survival into 
adulthood of 75-85% because of neurosurgical interventions [22, 23], reliable 
prediction of an individual long-term prognosis concerning quality of life (instead 
of survival alone) for a foetus or neonate born with a neural tube defect is still 
difficult [24,25,26]. 
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In counselling couples carrying a foetus with a neural tube defect, it is important 
to realise that the defect might be associated with other congenital malforma-
tions, e.g. in the context of a particular syndrome. In the literature, up to 20% of 
children with neural tube defects have coexisting abnormalities involving other 
than nervous system structures [26,27]. In 2011, Stoll et al published an article 
about their 30-year study during the period 1979-2009 including 441 pregnancies 
(including live births, stillbirths, and terminations of pregnancy) complicated by a 
neural tube defect [28]. In their population of North-Eastern France, 351 (79.6%) 
infants or foetuses had no congenital anomalies other than the neural tube defect 
(isolated defects), whereas 90 (20.4%) did have other malformations in addition 
to their neural tube defect (associated anomalies). The associated anomalies were 
divided into chromosomal conditions (n=11), non-chromosomal conditions with 
recognizable sequence or association (n=23), and multiple malformations without 
a recognizable pattern (n=56). Among the latter, the most frequent malforma-
tions were renal malformations, oral clefts, musculoskeletal malformations, and 
cardiac defects. Associated neural tube defects were more frequent among infants 
of foetuses with encephalocele (36.8%) than among those with spina biﬁda 
(23.8%) or anencephaly (11.5%). Among the recognizable conditions, amniotic 
bands sequence, Meckel–Gruber syndrome, and OEIS (omphalocele, extrophy of 
the bladder, imperforate anus, spinal defects) sequence were most often seen. 
Eleven chromosomal abnormalities were detected; all but one were trisomy 18, 
while one was an unbalanced translocation. 
Even for children with an isolated neural tube defect, the individual prognosis for 
the quality of life is hard to predict based on prenatal ultrasound examination. For 
parents, ambulation is a very important subject in counselling. It is often difficult to 
understand, however, that the presence of leg movements during pregnancy does 
not imply functional integrity of upper and lower motor neurons, so cannot be used 
as a prognostic marker [29,30]. Biggio et al (2001) examined prenatal lesion level 
by two-dimensional ultrasounds for the prediction of ambulatory status at 2 years 
of age in 33 foetuses with prenatally diagnosed open spinal dysraphism [31]. They 
found that lesion level on prenatal ultrasound was concordant with the postnatal 
diagnosis within two spinal levels in 92% of the cases. Regarding motor outcome, 
they found that none of the cases with thoracic lesions were ambulatory, 50% of 
cases with L1-L3 lesions were ambulant and 100% of cases with L4-S3 lesions were 
ambulant. The anatomical level of the spinal anomaly and head circumference are 
predictive of survival as well, but no obvious prenatal ultrasound predictors for 
quality of life and long-term neurodevelopmental outcome have been identified 
so far [32]. 
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Prenatal life – Foetal surgery
Because of the complexity of spinal dysraphism and its heterogeneity in presenta-
tion and outcome, a lot of research has been done worldwide concerning preven-
tion, early prenatal detection, and optimisation of perinatal and postnatal care for 
patients with a neural tube defect and their families. Among all of these efforts, 
the most recent, most impressive, and most promising approach to early interven-
tion is foetal, thus ‘in utero’, surgery. 
Foetal surgery is based on the theory that the pathogenesis of spinal dysraphism is 
explained by the so called ‘two-hit’ hypothesis [33]. Between the third and fourth 
week after conception, primary neurulation fails, an event referred to as the first 
‘hit’ [34]. As the pregnancy progresses, a ‘second hit’ is added: toxicity of amniotic 
fluid is thought to cause chemical injury, while shearing and abrasive stresses cause 
secondary mechanical damage to the delicate neural tissue [35, 36]. This ‘two-hit’ 
hypothesis prompted the question whether in utero closure of the defect would 
stop secondary damage.
Early animal studies and ultimately human pilot studies in the 1990s laid the ground-
work for the Management of Myelomeningocele Study (MOMS Trial) [37,38]. In 
this trial, the investigators studied the effects of ‘in utero’ surgical closure of the 
spinal defect in foetuses with spinal dysraphism on survival and postnatal neu-
rological outcome, especially the need for a cerebrospinal ﬂuid shunt, the scores 
of the Mental Development Index of the Bayley Scales of Infant Development II, 
and the child’s motor function. The ﬁrst primary outcome - i.e. the composite of 
foetal or neonatal death and the need for ventriculoperitoneal shunt placement 
before the age of 12 months - occurred in 68% of the prenatal surgery group and 
in 98% of the postnatal surgery group (p < 0.001). The need for a cerebrospi-
nal ﬂuid shunt was 40% in the prenatal surgery group and 82% in the postnatal 
surgery group (p<0.001). Motor function and ability to walk without orthotics 
or devices was better in the prenatal surgery group compared with the postnatal 
surgery group as well. Despite the evidence for improved outcomes after prenatal 
surgery for myelomeningocele repair, considerable risks for mother and child were 
associated with foetal surgery in this study. Chorioamniotic membrane separation 
(prenatal surgery: 26% vs. postnatal surgery: 0%, p < 0.001), spontaneous rupture 
of membranes (46 vs. 8%, p < 0.001), and spontaneous preterm labour (38 vs. 
14%, p < 0.001) are all major risk factors for preterm delivery and all occurred 
more frequently in the prenatal surgery group. This led to a lower gestational age 
at delivery in this group of 34.1 ± 3.1 weeks compared with 37.3 ± 1.1 weeks in the 
postnatal surgery group (p < 0.001). Maternal risks included pulmonary oedema 
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(prenatal surgery: 6% vs. postnatal surgery: 0%, p = 0.03) and blood transfusion at 
delivery (9 vs. 1%, p = 0.03). Overall, the hysterotomy was intact and well healed 
in two-thirds of patients at the time of delivery. The hysterotomy was thin in 25%, 
while 9% had an area of dehiscence with only one woman (1%) having complete 
dehiscence. The MOMS trial was generally regarded as a great success and led to 
a major paradigm shift in the world of foetal therapy, which had typically been 
reserved for life-threatening conditions so far. However, data on long-term out-
comes are not available yet, and prenatal surgery was associated with increased 
risks of maternal and foetal complications. In view of the positive results of the 
MOMS trial, the Belgian team decided to start offering foetal myelomeningocele 
repair at the Foetal Medicine Unit of the University Hospital Leuven (Belgium), 
starting January 2006 [39]. 
Postnatal life
Although the overall outcome of children with a spinal dysraphism has improved 
over the past decades, reliable prediction of the individual long-term prognosis 
for a neonate born with a neural tube defect is still difficult [24,25,26]. Several 
studies concerning survival and outcomes of patients with spinal dysraphism are 
available in the literature. Being independent in activities of daily living is an im-
portant prerequisite for quality of life and social participation. For parents of a 
child born with a neural tube defect and for patients themselves, it is important to 
have reasonable expectations about functional independence in the future [42]. 
Recently, Oakeshott et al published their long-term outcome data after a 50-year 
complete community-based prospective cohort study for treated neural tube de-
fects (n=117). In this cohort, those with the best results were born with a sensory 
level below L3 (i.e. sensation absent below the knee only). They were more likely 
to survive to adulthood, to walk, be continent of urine, to have normal intelligence 
(IQ ≥80), and to live independently in the community. The authors concluded that 
sensory level predicts outcome better than cutaneous or radiological level and 
should be assessed in all children born with a neural tube defect [43,44,45,46]. 
In addition to the range of medical and physical consequences, spinal dysraphism 
also has an impact on cognitive development. In general, children with a neural 
tube defect tend to have intelligence scores within the low-average to average 
range. The intelligence distribution is shifted towards the lower end of the spec-
trum by approximately one standard deviation [47,48,49]. Cognitive outcome is 
associated with numerous factors among which the severity or location of the spi-
nal defect: the higher the lesion, the poorer the cognitive outcome. Furthermore, 
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the presence of hydrocephalus is associated with poorer outcome [50], with the 
annotation that cognitive impairments are associated with the number of shunt-
related complications in particular [51]. Other studies suggested that cognitive 
outcome is associated with the impact of the hydrocephalus on cerebral white 
matter [52,53]. 
Aim and context of this thesis
The studies described in this thesis were performed within the Nijmegen Interdis-
ciplinary Spina Bifida Program, with participation of several disciplines, ranging 
from paediatric neurology, neuropsychology, clinical neurophysiology, neuroradi-
ology, obstetrics, and epidemiology at the Radboud university medical center to 
family pedagogy and empirical theology at the Radboud University. The aim of 
this thesis was to study infants with spinal dysraphism prenatally and postnatally 
to determine whether available diagnostic techniques would lead to better insight 
in the prognosis of their neurodevelopmental outcomes. Data collection started 
in January 2002. A cohort of 44 new-born infants with spinal dysraphism was 
prospectively included and followed into early childhood. In addition, a cohort of 
56 school-age children with spinal dysraphism was recruited from the outpatient 
clinics of the Radboudumc. Regarding the paediatric neurological part of the 
programme, data collection included prenatal ultrasound imaging, physical and 
neurological examination, MR imaging of the brain and spinal cord, and neuro-
physiological investigations. 
Outline of the thesis
Chapter 2 describes a retrospective study with assessment of the foetal biparietal 
diameter (BPD) and head circumference (HC) in the second trimester of preg-
nancy in foetuses with open spinal dysraphism to assess the prognostic values of 
BPD and HC. Chapter 3 describes a retrospective study to assess the influence of 
birth mode on early neurological outcome for infants with a myelomeningocele 
born at the Radboudumc between 1990 and 2006. Chapters 4 and 5 pertain to our 
cohort of prospectively included new-born infants with open spinal dysraphism. 
In the study described in Chapter 4, the prognostic value of neonatal electroen-
cephalography (EEG) for clinical and neuropsychological outcomes among these 
children was evaluated, while the study in Chapter 5 evaluated the predictive val-
ues of neonatal motor evoked potentials (MEPs) after transcranial and lumbosa-
cral magnetic stimulation and compound muscle action potentials (CMAPs) after 
electric nerve stimulation for neurological outcome at the age of two years. MEPs 
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and CMAPs were also assessed in our cohort of school-aged children with open 
spinal dysraphism and a group of control children in the study on motor impair-
ment described in Chapter 6. Finally, the general discussion of the main findings 
and the future perspectives are presented in Chapter 7. 
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Abstract
Objective: The aim of this retrospective study was to assess the fetal biparietal di-
ameter (BPD) and head circumference (HC) in the second trimester of pregnancy 
in fetuses with open spinal dysraphism. 
Methods: BPD and HC were measured at 16-26 weeks in 74 fetuses with open 
spinal dysraphism and compared to reference values. 
Results: BPD was smaller in fetuses with open spinal dysraphism. Of all cases with 
open spinal dysraphism, 62.2% had a BPD < 3rd percentile and 79.7% had a BPD < 
10th percentile. Of all patients, 54.1% had a HC < 3rd percentile and 74.3% had a 
HC < 10th percentile. 
Conclusion: Almost all fetuses with open neural tube defects have a smaller BPD 
and HC at 16-26 weeks compared with reference values, which implicates that 
this is part of the phenotype of children with open spinal dysraphism instead of an 
independent  prognostic marker for a poor cognitive outcome.  
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Introduction
Spinal dysraphism is a complex congenital malformation of the central nervous 
system with a prevalence of 1-5 in 10,000 live births worldwide [1,2]. Mortality 
rates have declined and likelihood of an independent living has improved over the 
past years. The majority of children with spinal dysraphism present with hydro-
cephalus and other associated cerebral malformations [3,4]. 
Since January 2006 every pregnant woman in the Netherlands is offered a standard 
anomaly 20-week ultrasound scan. Screening for fetal open spinal dysraphism is 
performed at this second trimester ultrasound scan. Scalloping of the frontal bones 
(the so called lemon sign) and a banana-shaped cerebellum because of Chiari mal-
formation are well-known fetal cranial features of spinal dysraphism that can be 
recognized at ultrasound screening [5,6]. Bernard et al [7] reported in 2012 that 
a reduced biparietal diameter (BPD) at 11-14 weeks of gestation is a simple and 
reproducible robust early marker of spinal dysraphism that could detect half the 
cases of open spinal dysraphism. As far as we know, BPD and head circumference 
(HC) as far as we know are not mentioned in the literature as a prognostic marker 
for neurodevelopmental outcome in children with open spinal dysraphism. The 
aim of this study was to assess fetal parameters such as BPD, HC, femur length 
(FL), abdominal circumference (AC), and transverse cerebellar diameter (TCD) in 
the second trimester of pregnancy in fetuses with open spinal dysraphism. 
Patients and Methods
All second-trimester biometrics of ultrasound scans of 74 prenatally diagnosed 
fetuses with open spinal dysraphism performed from 2006 through 2011 at the 
Radboud University Medical Centre Nijmegen were retrospectively collected. 
Prenatal ultrasound scan was performed during the 16-26 weeks by 2 certified 
technicians. 
Information concerning gestational age, BPD, HC, TCD, FL, and AC was recorded. 
BPD and HC were obtained in 74 fetuses, TCD measures were available in 56 fe-
tuses,  and AC and FL were measured in 73 fetuses. The BPD and HC values were 
obtained in a transverse view of the fetal head in a plane showing both the thalami 
and the third ventricle, from the outer border of the skull [8] (fig. 1). 
TCD was measured on a transverse view showing the cavum septum pellucidum 
and the cerebellum.
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Following standard practice in prenatal screening, the biometric measures are 
compared to published Dutch reference curves of fetal biometry according to 
Verburg et al [9]. In all cases BPD, HC, TCD, AC, and FL are expressed in numbers 
and percentage of fetuses with measures lower than 3rd, 10th, and 50th centile 
with confidence intervals for these percentages (table 1).
Fetal ventriculomegaly is defined as an enlargement of the atrium of the lateral 
ventricle. The diagnosis of ventriculomegaly is usually based on reference ranges 
established by Salomon et al.[10] in 2007, where the upper limit of the fetal 
ventricular measurement does not change across gestation. According to these 
criteria a width of less than 10.0 mm is considered normal. Measurements between 
10.0 and 15.0 mm are often described as mild or moderate ventriculomegaly and 
a measurement more than 15.0 mm as severe.
Results 
Figures 2-6 show individual BPD (fig. 2), HC (fig. 3), TCD (fig. 4), FL (fig. 5), and 
AC (fig. 6) measurements in relation to published references curves [9]. 
These figures show us small BPD and HC for fetuses with spinal dysraphism in the 
second trimester of pregnancy, whereas FL and AC are within the normal ranges.
BPD was smaller than the 3rd percentile in 62.2%, with a confidence interval far 
above the expected 3%; 1 patient had a BPD according to the expected 50th per-
centile and only 2 fetuses had a BPD above the expected 50th percentile. HC was 
Table 1. Biometric fetal measures
 
BPD (n = 74) HC (n = 74) TCD (n = 51) FL (n = 73) AC (n = 73)
n % n % n % n % n % 
<3rd 
percentile
46
62.2 
(51.1-73.2)
40
54.1 
(42.7-65.5)
36
70.6 (58.1-
83.1)
10
13.7
(5.8-21.6)
6
8.2 
(1.9-14.5)
<10th 
percentile
59
79.7 
(70.5-88.9)
55
74.3 
(64.3-84.3)
42
82.4 (71.9-
92.9)
14
19.2 
(10.2-28.2)
11
15.1
(6.9-23.3)
<50th 
percentile
71
95.9 
(91.4-
100.4)
68
91.9 
(85.7-98.1)
49
96.1 (90.8-
101.4)
40
54.5 
(43.1-65.9)
37
50.7 
(39.2-
62.2)
<90th 
percentile
            63
86.3 
(78.4-94.2)
64
87.7 
(80.2-
95.2)
Values in parentheses are confidence intervals.
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also smaller than the 3rd percentile in 54.1% of the fetuses. The TCD was smaller 
than the 3rd percentile for 70.6% of the fetuses, with all confidence intervals far 
above the expected 3, 10 en 50%. FL values were similar to 50th and 90th per-
centiles of the reference population. There were slightly more fetuses with an FL 
smaller than the 3rd and 10th percentile in comparison with the reference values. 
The AC for fetuses with an open spinal dysraphism were similar to reference values 
for healthy fetuses. 
In our population, lateral ventricular width was normal in 34 fetuses (46%). Mild 
ventriculomegaly was seen in 33 fetuses (45%) and severe ventriculomegaly was 
seen in 6 fetuses (8%). Of the 6 fetuses with severe ventriculomegaly, 3 fetuses 
had a small HC and BPD (2 at the 3rd percentile and 1 lower than the 3rd centile). 
The other 3 fetuses with a severe ventriculomegaly had an HC and BPD at the 
median. The ventricular width measure was missing for 1 fetus. 
Fig. 1. BPD: transverse view of the fetal head in a plane showing both the thalami and the 
third ventricle, from the outer border of the skull.
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Fig. 2. Individual BPD measurements in relation to published reference curves. 
Fig. 3. Individual HC measurements in relation to published reference curves. 
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Fig. 4. Individual TCD measurements in relation to published reference values. 
Fig. 5. Individual FL measurements in relation to published reference curves. 
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Fig. 6. Individual AC measurements in relation to published reference curves. 
Discussion
The BPD and HC are smaller in fetuses with spinal dysraphism in the second trimes-
ter of pregnancy in comparison with published reference values of healthy fetuses. 
In a retrospective study of 20 fetuses with spinal dysraphism published in 1980, 
Wald et al [11] described a significantly smaller BPD and assumed this could be 
due to growth restriction. In 1986, Nicolaides et al [5] reported the lemon and 
banana signs in 70 fetuses between 16 and 23 weeks of gestation, and they re-
ported a BPD smaller than the 5th centile in 61% and a smaller HC in 26%. Several 
studies have confirmed the observation of a small head in open spinal dysraphism, 
but later studies emphasized the obviously abnormal head shape and intracranial 
anatomy, focusing less on the small BPD or HC. 
The mechanism by which the normal bony posterior fossa develops is not known 
with certainty, but McLone and Dias [12] suggested that hydrostatic pressure 
transmitted through the cerebrospinal fluid is an important factor for normal 
development of the bony fossa posterior. According to this theory, the presence of
an open spinal dysraphism allows leaking of cerebrospinal fluid through the caudal 
end of the spinal anomaly during fetal life. Reduced hydrostatic pressures leads to 
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an abnormally small posterior fossa and Chiari malformation. Pathological studies 
of aborted fetal brains have shown that Chiari II malformation precedes the onset 
of hydrocephalus. Under normal circumstances, just prior to neural tube closure in 
humans, there is a temporary period during which the central canal is temporarily 
obliterated for at least 2 days [12]. The ventricular fluid is held within the cranial 
compartment under pressure and this maintains the distention of the develop-
ing ventricles. Neuronal migration from the ventricular germinal zone to cortical 
layers depends on distention of the ventricular system. Abnormal distention of 
the ventricles causes a disorganization of migration, leading to polymicrogyria, 
heterotopias and callosal dysgenesis. Disorganization of migration and a small 
posterior fossa with downward herniation of the cerebellum can be related to a 
small BPD and HC. 
Furthermore, downward displacement of the cerebellar vermis below the foramen 
magnum causes elongation and compression of the brain stem and obliteration 
of the fourth ventricle. This obstruction results in loss of extra-axial fluid volume 
between the fetal cortex and the skull. Open fetal surgery leads to reopening of 
the fourth ventricle and the extra-axial fluid spaces and normalization of the HC 
biometry [13.14].
An important limitation of this study is its retrospective nature. Clinical follow-
up data of all fetuses were not available. The strength of this study is the highly 
reproducible BPD as a routine second-trimester scan measurement. A low BPD is 
seen as a potential early marker for neural tube defects in the first trimester [7]. 
BPD values might be affected by structural anomalies or genetic disorders. A small 
BPD and HC can predict reduced brain growth and development or a chromo-
somal abnormality [15]. In our population, 38 parental couples decided to perform 
quantitative fluorescent polymerase chain reaction of cultured amniocytes, show-
ing 4 fetuses with trisomy 18, 1 female triploidy and 33 normal results. Overall, 
35 pregnancies were terminated, and fetal death occurred in 1 pregnancy. All 4 
fetuses with trisomy 18 had BPD and HC values below the 3rd percentile. Even if 
these 4 fetuses with trisomy 18 were ruled out of the results, overall BPD and HC 
for fetuses with open spinal dysraphism are smaller compared with normal fetuses. 
Neurodevelopmental outcome is highly variable in the population of open spinal 
dysraphism. Because we measured a complete unselected cohort of prenatally 
detected fetuses with neural tube defects in a period of 2006-2011, we expected 
to see the same known variation in neurodevelopmental outcome in our popula-
tion. Cognitive impairment in children with spinal dysraphism has frequently been 
attributed to the severity of the hydrocephalus and associated complications 
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such as shunt revisions, infections or seizures [16]. However, hydrocephalus and 
Chiari malformation do not occur independently in spinal dysraphism. Severe 
ventriculomegaly is also seen in fetuses with a small BPD, so it remains a challenge 
to disentangle hydrocephalus, Chiari malformation, small BPD, and HC because 
of their interrelatedness [17]. Small BPD and HC represent the consequences of 
obstruction of the fourth ventricle associated with Chiari II malformation, while 
a small BPD and HC in the case of normal or increased extra-axial fluid spaces 
could suggest a morphologically smaller brain with increased risk of poor cognitive 
outcome. The relationship between small BPD and HC to cognitive outcome in 
fetuses with normal brain volume and reduces extra-axial fluid spaces is poorly 
understood. 
In conclusion, BPD and HC are small in fetuses with open spinal dysraphism and 
should thus be considered part of its phenotype and not an independent prognos-
tic marker for poor cognitive outcome. 
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Abstract 
Objective: The aim of the study was to determine whether route of birth affects 
early neurological outcome in infants with myelomeningocele.
Study Design: In a retrospective cohort study, 95 neonates with myelomeningocele 
evaluated at the Radboud Nijmegen University Medical Centre between 1990 and 
2006 were reviewed. The effect of delivery mode on early neurological outcome 
was assessed as the difference between functional neurological level and X-ray 
level (ΔFAX).
Results: Early neurological outcome was better in the vaginally delivered infants 
(ΔFAX 0.96 ± 2.1) than in those delivered by cesarean section (ΔFAX 0.20 ± 2.5). 
After correction for confounders, multiple regression analysis demonstrated 
that vaginal delivery was associated with significantly better early neurological 
outcome as compared to cesarean section (β=1.21; 95% CI 0.16; 2.27; P=0.03) 
for infants in vertex and breech position combined. Subgroup analysis revealed a 
non-significant trend towards better outcome after vaginal delivery that was more 
pronounced in infants in breech position than in vertex position. 
Conclusion: In infants with myelomeningocele, born in either vertex or breech 
position, there is no clinical evidence that early neurological outcome is improved 
by cesarean section.
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Introduction
A neural tube defect is a severe congenital malformation, with a prevalence of 
1-5 in 10,000 live births worldwide [1,2]. The clinical spectrum of neural tube 
defects includes craniorachischisis, anencephaly, encephalocele, and spina bifida 
[3]. About 80% of the neonates born alive with a neural tube defect have a my-
elomeningocele [2]. Over the past decades the prognosis of neonates with myelo-
meningocele has improved significantly. In the 1950’s, 75% of the neonates with 
spina bifida died before the age of 1 year [4]. Since the 1960’s the survival rate has 
increased to 65% [5]. Advances in the quality and use of prenatal diagnostic imag-
ing have improved the obstetricians’ ability to diagnose the size and anatomical 
level of the lesion [2,6].  The number of life-born infants with myelomeningocele 
has declined in recent years as a result of pregnancy termination [7]. Women who 
continue their pregnancy, knowing that their child has myelomeningocele, need to 
be counseled as to the route of delivery.
The optimal delivery route in infants with a prenatal diagnosis of myelomeningo-
cele has been a matter of debate. In the absence of randomized controlled trials, 
evidence relies on case series. On the one hand, one has argued in favor of cesarean 
delivery on the assumption that increased pressure on exposed neural tissue dur-
ing vaginal delivery would result in additional loss of neural function, especially in 
case of breech delivery [8]. On the other hand, one has argued in favor of vaginal 
delivery primarily because of lack of evidence that cesarean section is of benefit 
[9]. In view of these conflicting policies, the aim of our study was to determine 
to what extent the route of delivery affects early neurological outcome in infants 
with myelomeningocele.
Materials and Methods 
The study was conducted as part of an ongoing investigation of prognostic and 
diagnostic interventions in children with spina bifida. All records of neonates 
evaluated for spina bifida born between 1990 and 2006 at the Radboud Univer-
sity Nijmegen Medical Centre were included in a retrospective review. Data were 
systematically collected from the medical records. Maternal data included age and 
parity. Infant data included gender, gestational age, mode of delivery, presenta-
tion at birth, birth weight, head circumference, and Apgar scores. Data on the 
co-morbidity of myelomeningocele included presence of hydrocephalus and Chiari 
malformation type II. Data considering the myelomeningocele itself included size 
of the spinal defect and leakage of cerebral spinal fluid. Special attention was paid 
to the anatomical and functional levels of the myelomeningocele. 
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Functional and anatomical levels of the myelomeningocele were measured dur-
ing the first, second and third day after birth, before surgical procedures were 
performed, as early neurological impairment is markedly influenced by surgery 
[10,11]. The anatomical level of the defect was defined as the anatomical X-ray 
level (AX), measured as the lowest intact vertebral arch of the spinal column on 
a standard anteroposterior X-ray. The functional neurological level (F) was mea-
sured as a composite of motor and sensory function; the lowest intact spinal seg-
ment on the most affected side of the body was taken as measure of severity. The 
criteria used to define ‘intact’ were voluntary muscle activity with a force equal to 
or greater than 3/5 on the Medical Research Council scale (MRC) and pain-touch 
discrimination, defined in newborns as the presence of behavioral reactions to pin 
prick and light touch and non-stereotypical, non-reflex movements. The effect 
of the mode of birth was determined as the difference between functional neu-
rological level and anatomical level (ΔFAX) and expressed as a numeric index as 
described by Luthy et al and depicted in Figure 1 [12]. Cervical lesions were num-
bered 1 through 8, thoracic lesions 9 through 20, lumbar lesions 21 through 25, 
and sacral lesions 26 through 29. No abnormality was numbered as 30. Functional 
spinal neurological impairment and anatomical level of the lesion were measured 
at the first three days after birth, before any surgical procedure was performed. 
Leg movements and tendon reflexes caudal to the myelomeningocele might disap-
pear during the first postnatal days as described by Sival et al [13], therefore we 
measured the functional levels during all first three days after birth and used the 
lowest measured level. A ΔFAX of 1 segment was considered clinically significant. 
A positive value of ΔFAX indicates that functional neurological impairment is bet-
ter than expected on the basis of the anatomical level; a negative value of ΔFAX 
indicates that impairment is worse. 
From the 150 neonates with spina bifida initially evaluated, 55 were excluded. 
Thirty-four infants had a diagnosis other than myelomeningocele, including lipo-
myeloschisis, spina bifida occulta, meningocele, craniorachischisis, and/or cervical 
lesions. Sixteen infants had incomplete data concerning route of delivery and or 
functional or anatomical level of the defect. Five infants had a ΔFAX of more than 
5 segments because of associated disorders, including three cases of Jarcho Levin 
syndrome [14], a congenital disorder characterized by vertebral and rib anomalies 
and associated with neural tube defects [15], one case of other vertebral anoma-
lies, and in one case there was an unexplained difference between the functional 
and anatomical level of 14 vertebral segments. The latter most likely was a coding 
error that could not be verified because the X-rays were no longer available. The 
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remaining 95 cases were analyzed for differences in neurological impairment, both 
as a group and subdivided by route of delivery. 
Fig. 1. ΔFAX indicates difference between functional and anatomical levels of neurological 
damage.
Statistical analysis
Continuous variables were normally distributed and are presented as means and 
standard deviations (± SD). Group differences were compared using independent-
samples t-tests. Nominal variables are presented as absolute numbers and percent-
ages and were compared using Chi square tests. Multiple linear regression analyses 
were performed with ΔFAX as dependent variable, without and with adjustment 
for the confounders birth weight, gestational age, and size of defect (SPSS for win-
dows version 17.0.1). Analyses were performed both for the group as a whole and 
separately vertex and breech position. A p-value of less than 0.05 was considered 
statistically significant.
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Results
Maternal and infant variables are presented in Table 1. From the 95 infants, 60 were 
born by the vaginal route and 35 by cesarean section. Subgroup analysis revealed 
no differences in early neurological outcome between prelabor cases (n=20) and 
cases exposed to labor (n=15). Therefore, the analyses were based on the total 
cesarean section group.  Cesarean section was planned because of the neural tube 
defect in 19 cases (54.3%), in 6 cases (17.1%) for obstetric reasons prior to labor 
and in 10 cases (28.6%) during labor. Among the 95 infants, the anatomical level 
of the defect was thoracic in 20 cases (21.1%), lumbar in 73 cases (76.8%) and 
sacral in 2 cases (2.1%). There was no significant difference in anatomical level 
of the defect between the group born by vaginal delivery or by cesarean section. 
The groups differed significantly for size of defect; the mean size was larger in the 
cesarean than in the vaginal group (5.9 ± 2.1 vs. 4.8 ± 1.8 cm). Breech position 
was more prevalent in the cesarean than in the vaginal group (37.1 vs. 16.7 %, ns). 
There was no significant difference in anatomical level of the defect between the 
group born in vertex or breech position. From the 23 infants in breech position, 13 
(57%) were delivered by cesarean section and 10 (43%) vaginally. The two groups 
were not different for the other variables. 
Regression analysis showed that for the group of infants with myelomeningocele 
as a whole neurological impairment was more favorable for vaginal than for 
cesarean delivery, corrected for the confounders birth weight, gestational age, 
and size of the defect (β=1.21; 95% CI 0.16; 2.27; p 0.03), as shown in Table 2. 
Subgroup analysis revealed a non-significant trend towards better outcome after 
vaginal delivery that was more pronounced in infants in breech position (β = 1.63; 
CI –0.15-3.41; ns) than in vertex position (β= 0, 72; CI –0.75-2.20; ns). Possible 
confounders, including parity and head circumference, did not have a significant 
effect on the effect estimates and were eliminated from the regression model. 
Comment
The optimal route of delivery for infants with a myelomeningocele remains a mat-
ter of debate. The question which route is best in vertex and breech presentation 
is difficult to answer in the absence of randomized controlled trials. Such trials 
have not been performed and are unlikely ever to be performed; especially now 
fewer infants with the anomaly are born, as a result of folic acid supplementa-
tion, structural anomaly scanning, and termination of pregnancy in recent years. 
Women who choose to continue their pregnancy still face the question how to 
39
Chapter 3 | Influence of Birth M
ode (of alternati
ef Birth M
ode)
deliver in their infants’ best interest. At present, the answer will has to come from 
observational studies.
In our retrospective cohort study of 95 infants with myelomeningocele, we 
measured objectively the functional and anatomical defect levels and determined 
the effect of mode of birth as the difference between functional and anatomi-
cal level as ΔFAX. A positive ΔFAX indicates that functional neurological level is 
better than expected of the anatomical level. Negative ΔFAX indicates a relative 
poor functional level. If vaginal delivery would harm and cesarean section would 
protect neurological function, one would expect ΔFAX to be smaller or negative 
in the vaginal group and positive in the cesarean group. In contrast with this, we 
found vaginal delivery protective (adjusted ΔFAX 1.21, CI 0.16-2.27, p 0.03). This 
suggests that in infants with myelomeningocele vaginal delivery is not harmful and 
cesarean section is not protective. 
Table 1.  Maternal and infants characteristics.
Vaginal delivery
(n=60)
Caesarean birth
(n=35) 
p-Value
Maternal
Age (years) 28.8 ± 3.8 28.8 ± 4.8 0.98
Parity ≥1 34 (56.7%) 19 (54.3%) 0.36
Infant
Male gender 31 (51.7%) 16 (45.7%) 0.40
Gestational age (weeks) 38.4 ± 2.7 38.4 ± 1.5 0.94
Birth weight (grams) 3080 ± 702 3095 ± 587 0.92
Head circumference (cm) 33.8 ± 2.6 34.7 ± 3.5 0.19
Apgar score 1 min 7.4 ± 1.9 7.8 ± 1.7 0.33 
Apgar score 5 min 8.9 ± 1.2 9.0 ± 1.0 0.23
Breech 10 (16.7%) 13 (37.1%) 0.08
Hydrocephalus 53 (88.3%) 35 (100%) 0.70
Size of defect (cm) 4.8 ± 1.8 5.9 ± 2.1 0.01*
Leakage of cerebral spinal fluid 35 (58.3%) 27 (77.1%) 0.36
Neurological outcome
ΔFAX 0.96 ± 2.1 0.20 ± 2,5 0.11
Values are absolute numbers with percentage in brackets or means ± SD. 
*p <0.05 for cesarean compared to vaginal delivery.
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One obvious limitation of our study is that selection of the delivery route was 
based on clinical judgment rather than randomization. It is therefore conceivable 
that infants with a larger defect and/ or in breech position were preferentially 
selected by the gynecologist for treatment by cesarean section to protect the 
neural elements, even if the clinical protocol did not prescribe that. We feel that 
this effect was not of paramount importance because we used the size of the 
defect as a confounder in our regression model and this factor did not influence 
the effect estimates. In addition, the apparent protective effect of vaginal delivery 
was largest in the breech group. 
The literature dealing with the preferred route of delivery in infants with myelome-
ningocele between 1970 and 2010 is shown in Table 3. The first article in favor of 
cesarean birth was published in 1970 [16]. A large occipito-frontal circumference 
(>35cm) was identified as a risk factor for vaginal delivery. Whereas 69 infants had 
a large occipito-frontal circumference, only 14 out of 130 (10, 8%) infants were 
delivered by cesarean section. In 1975 it was suggested on basis of post-mortem 
examinations that vaginal delivery would traumatize muscles, nerves, and soft tis-
sues of the lower extremities in infants with spina bifida in breech position [8]. All 
infants had been delivered vaginally, and were examined at up to several months 
postnatal, implicating that the effect of surgery could not be separated. In 1984 
atraumatic abdominal delivery was advocated for infants antenatally diagnosed 
to have myelomeningocele without further argumentation [17]. In 1987 Shurtleff 
Table 2. Difference between functional and anatomical levels (ΔFAX) in infants with my-
elomeningocele.
Effect on ΔFAX (β) (95% CI) p-Value
Total group
Vaginal vs. caesarean delivery +0.77 (-0.19 to +1.72) 0.11
Adjusted for confounders† +1.21 (+0.16 to +2.27) 0.03*
Infants in vertex position
Vaginal vs. caesarean delivery +0.05 (-1.37 to +1.36) 0.99
Adjusted for confounders† +0.72 (-0.75 to +2.20) 0.33
Infants in breech position
Vaginal vs. caesarean delivery +1.37 (-0.04 to +2.78) 0.06
Adjusted for confounders† +1.63 (-0.15 to +3.41) 0.07
ß, unstandardized coefficient. 
* p < 0.05 for vaginal compared to caesarean delivery.
† Adjustment for the confounders gestational age, birth weight, and size of defect.
41
Chapter 3 | Influence of Birth M
ode (of alternati
ef Birth M
ode)
et al suggested that elective prelabor cesarean section would reduce paralysis 
whereas delivery after the onset of labor would not [18]. They reported a benefit 
of a cesarean section only in neonates with presence of good intrauterine lower 
extremity movements and minimal or no evident hydrocephalus. Shurtleff et al 
Table 3. Literature on optimal route of delivery in infants with myelomeningocele, be-
tween 1970 and 2010. 
Author, year Number 
of patients 
(vaginal/
caesarean )
Outcome measures Level of 
evidence
Conclusion 
Stark et al., 
1970 [16]
130 (116/14) Birth injuries IV No preference
Ralis et al., 
1975 [8]
64 (64/0) Histological damage to 
muscles
IV Preference for cesarean
Chervenak et 
al., 1984 [19]
9 (5/4) Neurological evaluation at 
birth and at age 5, 11 or 17 
months old
III-b Preference for cesarea
Shurtleff et 
al., 1987 [18]
133 (98/35) Anatomical levels subtracted 
from the motor levels
III-b Preference for cesarean
Hadi et al., 
1987 [19]
8 (8/0) Neurological examination at 
birth, overall outcome at 1 
month to 5 years of age
V Preference for cesarean 
if breech presentation 
of hydrocephalus
Bensen et al., 
1988 [20]
72 (40/32) Bayley Scales of Infant 
Development and Vineland 
Adaptive Behavior Scale at age 
1 year
III-b No preference
Sakala et al., 
1990 [20]
35 (20/15) Apgar scores at 1 and 5 
minutes, Cele disruption
III-b No preference
Cochrane et 
al., 1991 [21]
208 (137/71) Motor and sensory 
neurological status at birth 
and later on during follow-up 
III-b Preference for 
cesarean only if breech 
presentation
Luthy et al., 
1991 [12]
160 (78/82) Motor and anatomical levels, 
Bayley Mental Development 
Index determined at the age 
of 24 months
III-b Preference for cesarean 
Merrill et al., 
1998 [22]
36 (21/15) Initial and final motor and 
anatomical levels
II-b No preference 
Lewis et al., 
2004 [23]
87 (43/44) Anatomical level of the lesion 
and initial (0-6 months) and 
long term (>10 years) motor 
level
II-b No preference 
Cuppen et al., 
2010
95 (60/35) ΔFAX day 1, 2 and 3 after 
birth, before surgical 
procedures were performed
II-b No preference
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introduced the difference between anatomic and functional levels as an outcome 
measure. In probably the most cited report, Luthy et al [12] in 1991 supported 
the use of planned cesarean delivery because in their patients they observed a 2.2 
times higher risk of severe paralysis at two years of age in infants exposed to labor 
contractions; the effect of surgery could not be separated. 
In contrast, also articles were published in favor of vaginal delivery. In 1987 the 
view that cesarean delivery would be of any benefit was rejected on the basis of 
eight infants with myelomeningoceles reported not to have ruptured celes during 
vaginal delivery [19]; the defects were less than 4 cm and no direct comparison 
with cesarean section was made. Clinicians may be tempted to perform cesarean 
section based on concerns about the neurological impact of possible rupture of 
celes during vaginal delivery, including ascending infection, cerebellum protrusion, 
or nerve damage. Our data do not provide further insight on this point. From the 
literature, however, we know that there is no evidence that the risk of cele rupture, 
or its complications, is any higher during vaginal delivery than during cesarean sec-
tion [20]. In 1988 a larger study reported that 40 infants with spina bifida aperta 
were born by the vaginal route without damage as determined by Bayley Scales of 
Infant Development (BSID)-scores at one year of age [9]; the type of spina bifida 
aperta was not specified. In 1990 35 infants with myelomeningocele were evalu-
ated in terms of fetal distress, cele disruption and need for shunting [20]. They 
reported no difference in immediate or long-term outcome, but did not report 
actual functional neurological outcome. In 1991 Cochrane et al [21] concluded 
that the benefit of prelabor cesarean delivery remained unproven. Unfortunately, 
they incorrectly used the best side to assess function and did not compare the 
difference between functional and anatomical level. In 1998 no significant differ-
ence was observed in ΔFAX between infants born vaginally or by cesarean section. 
The authors used a rough effect size of ΔFAX > 2.2 spinal segments for power 
calculations resulting in a small sample size. This was incorrectly based on the 2.2 
segment difference for mean ΔFAX values between infants born vaginally or by 
cesarean section reported in the study of Luthy et al. Besides that they used the 
functional neurological level measured at 3-4 years of age instead of at neonatal 
age, implicating the influence of surgery could not be separated [22]. In 2004 
Lewis et al [23] also described no benefit of cesarean section, but they used the 
ambulation status at age 2-10 years as an outcome measure instead of early out-
come measures.
Clearly all available studies either in favor or against cesarean delivery have their 
limitations, including case selection, outcome measures, retrospective data, and/ 
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or small sample size. There is no evidence to indicate that infants with myelome-
ningocele in vertex position do benefit from cesarean section. Our data suggest 
that the same is true for infants with myelomeningocele breech presentation. 
However, many gynecologists now consider breech presentation as an indication 
for cesarean section in itself. Although it may be contra intuitive for some physi-
cians that there would be no benefit of cesarean section in case of an infant with 
a myelomeningocele, others might argue that the vaginal birth canal is a more 
appropriate passageway than abdominal delivery, in which the uterine incision is 
often narrow and the angle of removal of the infant from the uterus is more abrupt. 
In conclusion, there is no evidence that cesarean section has a beneficial effect on 
neurological outcome in infants with myelomeningocele. Cesarean section should 
be performed on obstetric indication only. 
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Abstract
Objective: The aim of this prospective study was to assess the prognostic value of 
electroencephalography in infants born with spina bifida.
Methods: 31 infants with spina bifida born between 2002 and 2007 at the Radboud 
Nijmegen University Medical Centre were evaluated and followed for 2 and a half 
years. Electroencephalography (EEG) was performed during the first 8 weeks after 
birth.   
Results: EEG recordings were all within normal limits and showed no abnormalities. 
3 of the 31children showed mild mental disability and major physical disabilities at 
the age of 30 months.
Conclusion: Single Infantile EEG recordings are of limited prognostic value for 
infants born with spina bifida. Serial EEG recordings in combination with other 
clinical or neurophysiological investigations might ameliorate the contributing 
predictive value of neonatal EEG.
Abbreviations
BSID-II  Bayley Scales of Infant Development Second Edition
CT  Computed Tomography
EEG  electroencephalography
MDI  Mental Development Index
MRC  Medical Research Council scale
MRI  Magnetic Resonance Imaging
PDI  Psychomotor Development Index
RSFNE   Radboud University Nijmegen Medical Centre Score Form for Neona-
tal EEGs
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Introduction
Spina bifida is a severe congenital malformation with a prevalence of 1-5 in 
1,000 live births worldwide [1], which is associated with complex physical and 
neuropsychological morbidity. The majority of children with spina bifida have a 
hydrocephalus and associated cerebral malformations [3].
The intellectual skills of these children are often in the low average range of 
normal. The cognitive profile is in many respects similar to that of children with 
hydrocephalus of other aetiologies [2]. 
Nowadays, where choices have to be made regarding continuation or termina-
tion of treatment of neonates with spina bifida, it is important to have a set of 
early parameters to predict the neurodevelopmental outcome. It is generally ac-
cepted that neonatal electroencephalography (EEG) is a powerful tool to assess 
the prognosis of cognitive impairment in (pre-)term infants. Markedly abnormal 
background patterns are associated with poor neurological outcome while normal 
background patterns are associated with good neurological outcome [5,7,10]. 
Since neural tube defects are associated with cerebral dysgenesis, we hypothesize 
that EEG recordings might differentiate between those with and without cerebral 
comorbidity. This is the first study comparing early infantile EEG recordings of 
infants with a neural tube defect. 
Patients and Methods
Thirty-one infants with spina bifida, thoroughly investigated at the Radboud Uni-
versity Nijmegen Medical Centre during 2002-2007, were included in this prospec-
tive study. The experimental procedures were approved by the Regional Commit-
tee on Research Involving Human Subjects and written consent was obtained from 
the parent(s) of all children. The main inclusion criteria were (i) the presence of 
a congenital defect in the closure of one or more vertebral arches in combination 
with a median skin defect and/or a cystic or lipomatous lump on the back, and/
or a developmental anomaly of the spinal cord confirmed by Magnetic Resonance 
Imaging (MRI) and (ii) complete neuropsychological testing performed at the age 
of 30 months or known school performances. 
The spinal anomaly was further specified according to three characteristics: (i) 
Type of spinal anomaly scored with diagnostic codes as closed or open [8]; (ii) Ce-
rebral comorbidity scored as hydrocephalus and/or Arnold-Chiari II malformation 
based on MRI or Computed Tomography (CT) features; (iii) Functional neurologi-
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cal impairment measured as a composite of motor and sensory function, measured 
within three days after birth, before any surgical procedure had been performed. 
The lowest intact spinal segment on the most affected side of the body was taken 
as measure of severity. Criteria used to define ‘intact’ were voluntary muscle activ-
ity with a force equal to or greater than 3/5 on the Medical Research Council scale 
(MRC) and pain-touch discrimination, defined in new-borns as the presence of 
behavioural reactions to a pin prick and light touch which were non-stereotypical, 
non-reflex movements.  Motor and sensory impairment levels of the defect were 
converted to a numeric index as described by Luthy et al. [6].  
EEG was performed during the first 2 months of life. All EEGs were reviewed by the 
same electroencephalographer (JP) who was blinded to the functional outcome. 
Information concerning gestational age, postconceptional age, birth weight, and 
drug administration were available. Only EEG records with a duration of more than 
30 minutes  and compromising sleep and wake patterns were included. 
Semi-quantitative examination was done for:
(i) background activity, divided into amplitude, continuity, interhemispheric asyn-
chrony/asymmetry, maturation and organization of behavioural states and wave 
form morphology; (ii) normal transients, such as frontal transients, delta brushes 
and temporal saw tooth and abnormal transients, such as positive sharp waves; 
(iii) electrographic convulsive activity.
Based on the outcome of these items, the EEG was classified into 1 of 4 categories 
according to the criteria used by Lombroso, Rowe and Watanabe [5,9]: normal, 
mildly abnormal, moderately abnormal and major abnormal.
The latter two categories indicate features for an unfavorable prognosis, whereas 
the first category is considered to indicate a favorable prognosis.
Follow-up clinical and neuropsychological examination took place at 30 months of 
age, and data were collected about shunt problems/revisions and clinical episodes 
of epileptic activity confirmed by EEG recordings. The Bayley Scales of Infant 
Development Second Edition (BSID-II) were used, yielding two scores, the Mental 
Development Index (MDI) and the Psychomotor Development Index (PDI), both 
of which have a normative population mean of 100 and an SD of 15. The outcome 
was classified according to the Bayley Developmental Index Score Classification, 
in the following ranges: below 70, severely delayed development; 70-84, delayed 
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development disability; 85-114, normal development; and 115 and over, develop-
ment above normal.
Results 
Maternal and infant characteristics are presented in Table 1. Of the 31 infants, 28 
cases (90%) were born with an open defect (25 of which with myelomeningocele) 
and 3 (10%) with a closed spinal anomaly. 13 (42%) were born by caesarean sec-
tion.  The average age at the first EEG recording was 15 days after birth (range 
2-55 days). After adjustment for gestational age, all infantile EEG recordings were 
classified as normal. Background activity was normal. Normal frontal transients 
were recorded in 27 infants (87%), while none of the EEG recordings showed ab-
normal positive sharp waves and/or electrographic convulsive activity. Of the 31 
children, 20 patients underwent neuropsychological and physical investigation at 
the age of 30 months old. Eight children could not be examined because of refusal 
to participate (n=7) or insufficient command of the Dutch language (n=1). School 
performance levels were obtained for these 8 children, six of them attended normal 
primary school and two attended special primary school for children with physical 
disabilities only, suggesting normal cognitive development. Of the remaining three 
children, one passed away at the age of 19 months while suffering from an upper 
respiratory infection and two children were lost to follow up because of emigration. 
For the 20 children who underwent neuropsychological testing, the mean MDI- 
and PDI-score were 88 (range 55-140; SD 20) and 62 (range 55-92; SD 15), 
respectively. Twelve children (60%) had average cognitive test results (MDI 85-
114), while only one child (5%) showed a MDI score of >115. Four patients (20%) 
showed MDI-scores of >1 standard deviation below the mean (MDI<85), three chil-
dren (15%) had MDI-scores at >2 standard deviations below the mean (MDI<70). 
These children are shown in Table 2. All three children had hydrocephalus requiring 
shunt placement. Besides that, patient number 1 had a Chiari Malformation and 
developed convulsions after closing of the defect on day 2 after birth and epilepsy 
at the age of 3 years old. Patient number 2 underwent two drain revisions and 
developed epilepsy at the age of 27 months old. Patient number 3 was born with a 
microcephaly and was operated twice for a fossa posterior decompression because 
of symptomatic Chiari malformation. They had major disabilities at 30 months, but 
the infantile EEGs, adjusted for gestational age were normal. 
Four (13%) patients developed epilepsy at an average age of 35 months (range 
27-48 months). All four were born with meningomyelocele and hydrocephalus; 
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two were operated because of a dysfunctional shunt. EEG recordings in the 
infantile phase were normal. Two of these four patients had a severely delayed 
development (MDI<55). 
Table 1. Maternal and Neonatal characteristics
Spinal anomaly
Open anomaly
(n=28)
Closed anomaly
(n=3)
Maternal 
age (years) 31 (± 5.1) 28 (± 4.4)
parity > 1 21 (75%) 2 (67%)
Infant
cesarean section 13 (46%) 0 (0%)
male sex 15 (54%) 1 (33%)
gestational age (weeks) 38.8 (± 1.6) 40.6 (± 0.7)
birth weight (grams) 3149 (± 556) 2830 (± 407)
head circumference (cm) 34.0 (± 2.4) 36.0 (± 4.5)
apgar score 1 minute 8.0 (± 2.1) 9.0 (± 0.0)
apgar score 5 minutes 9.0 (± 1.0) 9.7 (± 0.6)
size of defect (cm) 5 (± 1.8) 5.0 (± 0.0)
radiological level of anomaly 22.8 (± 1.8) 23.0 (± 2.0)
functional motor level 23 (± 2.3) 26.7 (± 0.6)
functional sensory level 24 (± 3.2) 30.0 (± 0.0)
Cerebral comorbidity
Arnold Chiari malformation 25 (89%) 0 (0%)
hydrocephalus 26 (93%) 0 (0.0%)
shunt 22 (79%) 0 (0.0%)
drain revision(s) 17 (62%) 0 (0.0%)
EEG characteristics
pattern adjusted for gestational age Normal Normal
duration of EEG registration (min) 32 (± 6.5) 33 (± 2.9)
percentage of sleep 26% 18%
frontal transients (number of patients) 25 2 
central temporal positive spikes (number of patients) 0 0
electrographic infantile convulsive activity (number of patients) 0 0
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The aim of our study was to compare early EEG recordings in infants with 
spina bifida to neurodevelopmental outcome. All EEG recordings showed normal 
background patterns adjusted for gestational age. However, three children who 
developed a hydrocephalus requiring shunt placement had MDI-scores at least 2 
standard deviations lower than the normal Mental Development Index value. 
In the first two patients, the hydrocephalus and multiple drain revisions may have 
attributed to a poor neurodevelopmental outcome. The three sisters of the third 
patient were also born with spina bifida suggesting an underlying genetic abnor-
mality.
Prediction of the long-term neurolodevelopmental outcome of infants born with 
spina bifida has been attempted with a variety of techniques including neurological 
examination, neuroimaging and neurophysiological evaluation, but there is no con-
sensus as to which investigations should be performed. Decisions about treatment 
of patients with spina bifida are not based on international agreements either. 
Table 2. Patients Characteristics for children with low mental development index.
Patient number 1 2 3
apgar scores 1 and 5 min 8/10 9/10 9/9
type of defect Meningomyelocele Meningomyelocele Myeloschisis
functional motor level 22 25 25
functional sensory level 21 30 30
Arnold Chiari malformation Yes Yes Yes
hydrocephalus Yes Yes Yes
age at ventriculo-peritoneal drain 
placement (days)
7 25 9
drain revision 1 2 1
epilepsy Yes Yes No
EEG (performed at age in days of life) Normal (19) Normal (16) Normal (16)
educational level mother University University Middle vocational 
level
educational level father Higher vocational 
level
University Lower vocational 
level
psychomotor development index Unkown Unknown <55
mental development index <55 <55 <55
Mental development index and psychomotor development index according to the Bayley scales of 
infant development second edition (BSID-II).
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The prognostic value of a single EEG recording in infants with spina bifida is 
limited. Neural tube defects are congenital malformations of the central nervous 
system with a remarkable heterogeneity in associated brain malformations. The 
neurodevelopmental outcome of these infants is determined by multiple factors. 
Hydrocephalus, for instance, is not a reliable predictor for neurological outcome in 
children with spina bifida [4].  In our study, all infantile EEGs were normal despite 
known congenital brain anomalies. In the literature, the prognostic value of EEG 
in (pre-)term infants has been well documented for acquired brain lesions such 
as infants with hypoxic ischaemic encephalopathy. For infants with spina bifida, 
acquired brain development disorders, as a result of shunt malfunctions and infec-
tions, might cause EEG abnormalities and be of prognostic value. The neurode-
velopmental outcome seems to be negatively affected by drain revisions, other 
complications and underlying genetic aetiology. 
Serial EEG recordings may be recommended because brain maturation is also 
important for the prognosis of neurodevelopmental outcome. Furthermore, EEG 
recordings in combination with neurological examination, neuroimaging and other 
techniques such as magnetic evoked potentials may be a useful screening proce-
dure to predict neurodevelopmental outcome in children with spina bifida. 
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Appendix
Supplement: Radboud University Nijmegen Medical Centre Score Form for Neonatal EEGs (RSFNE)
Radboud University Nijmegen Medical Centre Score Form for Neonatal EEGs (RSFNE)
Written by: J. W. Pasman, neurologist/clinical neurophysiologist
PATIENTS DATA
Name:
Date of birth:
Gestational Age (weeks):
Age at day of EEG: 
Medication:
Respiration:
Sedation:
Date of EEG:
(i) BACKGROUND
Percentage Wake: Continous:
Dyscontinous:
Interburst seconds:
Percentage Sleep: Continuous :
Dyscontinuous :
Interburst seconds :
Electrocerebral inactivity: Yes/No
Continuous:  low voltage undifferentiated pattern/diffuse 
delta pattern
Burst-suppression: Burst: …seconds and …µV
Interburst: …seconds
Discontinous pattern: Burst:  …seconds and …µV
Interburst: …seconds and …µV
(ii) TRANSIENTS
δ-brushes : central/occipital/frontal: no/little/many
(a)symmetry
Transients (in narrow sense): frontal/occipital: no/little/many
(a)symmetry
Temporal saw-tooth: no/little/many
(a)symmetry
Positive sharp waves: temporal/rolandic: no/little/many
(a)symmetry
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(iii) ELECTROGRAPHIC CONVULSIVE ACTIVITY
Electrographic neonatal convulsions 
(duration > 5 seconds): 
no/sporadic/frequent/continuous uni-/
multifocal
Brief Ictal Rhythmic Discharges (BIRDS 
< 5 seconds):
no/sporadic/frequent uni-/multifocal
Rhythmic burst across the midline: no/little/many and Right/Left
Occipital spikes and sharp waves: no/little/many and Right/Left
Focal spikes and sharp waves: no/little/many and Right/Left
Multifocal ictal discharges: no/little/many and Right/Left
Generalized or focal pseudo delta/
theta/alpha/beta activity: 
no/little/many and Right/Left
Low frequent dichotic discharges: no/little/many and Right/Left
(iv) REACTIVITY
Acoustical stimulus: Yes/No
Pain stimulus: Yes/No
Fotostimulus: Yes/No
(v) CONCLUSION
Ground pattern is: in accordance with gestational age
OR Less developed for gestational age
This EEG is: (a) normal
(b) mild abnormal
(c) moderate abnormal
(d) major abnormal
(e) iso-electric
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Abstract
MEPs and CMAPs as prognostic tools for spina bifida.
Aim: The aim of this prospective study was to determine the prognostic value of 
neurophysiological investigations compared to clinical neurological examination in 
infants with spina bifida. 
Method: Thirty-six neonates born with spina bifida between 2002 and 2007 were 
evaluated and followed for 2 years. Lumbar motor evoked potentials (MEPs) and 
compound muscle action potentials (CMAPs) were obtained at the median age of 
2 days old before surgical closure of the spinal anomaly. MEPs were recorded from 
the quadriceps femoris, tibialis anterior, and gastrocnemius muscles and CMAPs 
from the latter two muscles. Areas under the curve and latencies of the MEPs and 
CMAPs were measured. Clinical neurological outcome at the age of 2 years was 
described using Muscle Function Classes (MFCs) and ambulation status. 
Results: The areas under the curve of MEPs and CMAPs in the legs were associated 
with lower neonatal levels of motor and sensory impairment. Better muscle function 
class of the lower limbs at 2 years of age was associated with larger MEP and CMAP 
areas of the gastrocnemius and tibialis anterior muscles at neonatal age. 
Interpretation: MEPs and CMAPs of the gastrocnemius and tibialis anterior 
muscles are of prognostic value for clinical neurological outcome in neonates born 
with spina bifida. 
Abbreviations
Cm Centimeter
CMAP Compound Muscle Action Potential
CT Computed Tomography
GC Gastrocnemius Muscle
MEP Motor Evoked Potential 
MFC Muscle Function Class 
MRC  Medical Research Council scale
MRI  Magnetic Resonance Imaging
QF Quadriceps Femoris muscle
TA Tibialis Anterior muscle
Th Thoracic
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1. Introduction
Spina bifida is a severe congenital malformation with a prevalence of 1-5 in 10.000 
live births worldwide.1,2 It is associated with complex physical and neuropsycho-
logical morbidity.3,4 In this century, where choices have to be made regarding 
continuation or termination of treatment of neonates born with spina bifida, or 
regarding new treatment options such as prenatal surgery, 5 it is important to have 
instruments to estimate the degree of neurological impairment. 3,6 Traditionally, 
neurological impairment has been assessed by physical examination after birth,7,8 
but potentially confounding factors are inconsistencies between muscle activity 
and neurosegmental innervations,9-11 the distinction between normal and purely 
reflex movements,12,13 and changing movement patterns during the first weeks of 
life.11, 14, 15  A variety of other methods, including prenatal ultrasounds,16 neuroim-
aging, and neurophysiological evaluation15 have also been used in an attempt to 
predict the long-term neurodevelopmental outcome of neonates born with spina 
bifida.17,18  Instruments providing additional information about neurological impair-
ment are desirable and may improve the preoperative clinical decision-making 
process in newborn infants with spina bifida.
Modern neurophysiological methods, such as motor evoked potentials (MEPs) 
may provide this additional information. Magnetic stimulation is a non-invasive 
method to evaluate motor pathways, which has diagnostic value in several disor-
ders.19 Previously, the feasibility of using lumbar magnetic stimulation in newborn 
infants with spina bifida was reported,20 as well as the relation between compound 
muscle action potentials (CMAPs) and early neurological impairment in neonatal 
spina bifida.21 
The aim of the present study was to investigate the prognostic value of MEPs and 
CMAPs for neurological impairment in children with spina bifida at 2 years of age 
compared to neonatal clinical neurological assessment. 
2. Method
2.1 Participants
Thirty-six newborn infants (22 boys, 14 girls) with spina bifida, recruited at the 
Radboud University Nijmegen Medical Centre during the period 2002-2007, were 
included in this prospective study. The study protocol was approved by the Regional 
Committee on Research Involving Human Subjects and written informed consent 
was obtained from the parent(s) of all children. Inclusion criteria were presence of 
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a congenital defect in the closure of one or more vertebral arches in combination 
with a median skin defect, and/or a cystic or lipomatous lump on the back, and/or a 
developmental anomaly of the spinal cord confirmed by Magnetic Resonance Imag-
ing (MRI). The congenital anomaly was further specified according to the following 
two characteristics: (1) Type and size of spinal anomaly scored with diagnostic 
codes as closed or open. An open neural tube defect, such as a myelomeningocele 
or meningocele, is characterized by exposure of nervous tissue and /or meninges 
to the environment through a congenital bony defect. A closed neural tube defect 
is covered with skin.22 (2) Cerebral comorbidity scored as hydrocephalus and/or 
Arnold-Chiari II malformation and/or corpus callosum dysgenesis based on specific 
Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) features. Dur-
ing the study all infants took part in the same rehabilitation program. They were 
seen in our “spina bifida” follow up outpatient clinic every 6 months, comprising 
of a permanent multidisciplinary team of doctors, including a child rehabilitation 
specialist, paediatric physiotherapist, orthopaedic surgeon and paediatric neurolo-
gist. Their advice was incorporated by the regional rehabilitation centres. 
2.2 Neurophysiological Assessment
Neurophysiological assessment was performed at the median age of 2 days after 
birth (range 0-18 days), before surgical closure of the spinal anomaly. The infants 
were investigated lying in prone position in an incubator while MEPs and CMAPs 
were recorded bilaterally from the tibialis anterior (TA) and the gastrocnemius 
muscles (GC), as well as MEPs from the quadriceps femoris (QF) using surface 
electrodes (tendon belly montage) and an Oxford Synergy electromyograph (Ox-
ford Instruments, Old Woking Surrey, UK; band-pass filter 20 Hz and 3 kHz, am-
plifier range 100 mV, and display sensitivity of 0.5 mV/division). Spinal magnetic 
stimulation (100% stimulation intensity) was performed with the coil positioned 
over the lumbosacral spine and was repeated several times with slight variations 
in coil position (including alternation of clockwise and counter-clockwise current 
flow in the coil) in search of the best reproducible MEP. In all infants, the same 
assessor performed the MEP procedure using a Magstim 200 magnetic stimula-
tor and a 90 mm circular coil (outer diameter 130 mm, inner diameter 50 mm). 
The MEP with the highest amplitude was used for further analysis. Supramaximal 
percutaneous electrical stimulation of the peroneal and posterior tibial nerves 
respectively were obtained at the popliteal fossa. The onset latencies (ms) from 
the stimulus artefact to the onset of the first negative deflection and the area 
under the curve of the first negative wave (mV ms) of the MEP and CMAP were 
measured. Because the area under the curve is less liable to dispersion than the 
amplitude, this was calculated as measure of the magnitude of the MEP or CMAP 
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(Fig. 1). 23-25 Measurements of the gastrocnemius muscle were obtained in only 
23 infants as this muscle was added to the protocol later during the investigation. 
Figure 1. Measurements of compound muscle action potential, the asterisk indicates stim-
ulus artifact. 
2.3 Radiological Assessment
Magnetic Resonance Imaging (MRI) of the whole neural axis was performed in all 
infants before surgery using a 1.5 T MR imaging unit (Siemens Avanto; Siemens 
Medical Solutions, Erlangen, Germany) with a standard head coil. T1-weighted im-
ages in the sagittal plane and T2-weighted images in the axial and coronal plane 
were acquired.The spinal anomaly was classified as closed or open spinal disraphism 
22. In addition, the presence of Chiari II malformation, hydrocephalus, or callosal dys-
genesis was assessed. The anatomical level of the defect was defined as the lowest 
intact vertebral arch of the spinal column on the sagittal T1- weighted images. 
2.4 Clinical Assessment 
2.4.1. Neonatal assessment
Clinical neonatal assessment was based on repeated physical examination within 
72h after birth before surgical procedures were performed, as neurological impair-
ment is markedly influenced by surgery.26,27 All children were examined by the 
same two paediatric neurologists. Motor impairment was assessed on each side 
separately and scored according to the lowest intact spinal segment with lasting 
non-stereotypical, non-reflex lower limb movements. Sensory impairment was also 
assessed on each side separately and scored according to the lowest intact derma-
tome, defined as the presence of behavioural reactions to pin prick and light touch. 
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2.4.2. Outcome assessment at the age of 2 years
Two outcome measures were assessed at 2 years of age. First, muscle function 
classes (MFC) according to McDonald10 based on the muscle strength in the lower 
limb muscles were used as a measure of impairment. Children were categorized 
into 1 of 5 MFCs. MFC I indicates good to normal intrinsic foot muscles (plantar 
flexion MRC grade 4-5); MFC II indicates weakness of plantar flexion (MRC grade 
≤ 3), good to normal knee flexion (MRC grade ≥ 3), and poor to fair or better hip 
extension and/or abduction activity (MRC grade ≥ 2) ; MFC III indicates good to 
normal hip flexion and knee extension (MRC grade 4-5), weakness of knee flexion 
(MRC grade ≤ 3), and traces of hip extension, hip abduction, and below-knee 
muscles; MFC IV indicates weak or no knee extension with poor or less hip flexion 
(MRC grade ≤ 2) and good pelvic elevation activity; MFC V indicates no muscle 
activity in the lower limbs. As a second outcome measure ambulation was assessed 
and classified in three categories: (a) community ambulation, when walking out-
doors, (b) household ambulation, if only walking indoor, and (c) non-functional 
ambulation. 
2.5. Statistical analysis
For the analysis, the motor and sensory impairment levels of the defect were 
converted to a numeric index: 1 for Th1, 2 for Th2, etcetera, until 22 (S5) and 
the Muscle Function Class scores were dichotomized into two groups, MFC I and II 
as group 1 (mildly impaired subgroup) and MFC III, IV and V as group 2 (severely 
impaired subgroup), because of expected community ambulation for MFC I and II 
and only household or non-functional ambulation for the other classes. Because of 
possible differences between the left and right side of the body for muscle function 
class, analyses were done for each side of the body separately. Ambulation was 
also dichotomized into community ambulators and non-community (household 
and non-functional) ambulators. 
As measurements of the gastrocnemius muscle were added to the protocol later, 
our study population comprised two subgroups, with and without measurements 
of the gastrocnemius muscle. Possible differences in clinical impairment and MEP 
and CMAP measurements between these subgroups were analyzed using the 
Mann-Whitney U test because of non-normal distributions. For the MEP and CMAP 
measurements, median values and ranges were computed. 
Associations of MEPs or CMAPs with neonatal clinical neurological impairment 
measures as well as with Muscle Function Classes and ambulation at two years of 
age were further analyzed with Spearman rank correlation coefficients and the 
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Mann-Whitney U test, respectively. Statistical analyses were performed using SPSS 
version 17.0.1. A p-value of less than 0.05 was considered statistically significant.
Results
3.1. Patients
Infant characteristics (n=36) are presented in Table 1. Fifteen infants were 
diagnosed antenatally. Most infants were born at term (median gestational age 
39 weeks; range 35-42 weeks) and had a birth weight and head circumference 
appropriate for gestational age (median birth weight 3245 g; range 2305-4100 g; 
median head circumference 34.7 centimetres (cm); range 30-46 cm). Most spinal 
anomalies were classified as open disraphisms (n=33). Thirty-one infants (86.1%) 
had a Chiari II malformation, thirty infants (83.3%) had a hydrocephalus, and 28 
infants (77.8%) had corpus callosum dysgenesis.
3.2 Neurophysiological assessment
3.2.1. Motor evoked potentials
Spinal magnetic stimulation resulted in MEPs in almost all infants. In 27 of the 36 
infants (75%), all investigated lower limb muscles responded to lumbar magnetic 
stimulation. In 8 infants (22%), one or more muscles did not respond. In only 1 
infant, no MEPs were obtained in any of the investigated lower extremity muscles. 
The median values and ranges of the latency and the area under the curve of the 
MEPs obtained are presented in Table 2. The quadriceps femoris muscle differed 
from the other muscles: shorter latencies and mostly larger MEP areas were seen, 
but only the shorter latencies were statistically significantly different. 
3.2.2. Compound muscle action potentials
The muscles responded to percutaneous electrical nerve stimulation in almost all 
infants: the TA in 31 of the 36 infants (86%) and the GC in 20 of the 23 infants 
(87%). If the GC did not respond, neither did the TA. The median values and 
ranges of the latency and the CMAP area are shown in Table 3. Some differences 
were noticed between the two muscles. The gastrocnemius latencies were slightly 
longer than the tibialis anterior latencies, while gastrocnemius areas were smaller. 
The variability in the CMAP area was larger for the gastrocnemius muscle than for 
the tibialis anterior muscle. 
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Only slight left-to-right differences were observed for MEP and CMAP parameters, 
but none of these were statistically significant. No differences were present 
between the subgroup in which only the tibialis anterior and quadriceps femoris 
muscle were investigated (n = 13) and the subgroup in which all three lower ex-
tremity muscles were investigated (n = 23). Therefore, further analyses pertain 
to the total group of patients, while results are presented for the right side only.
3.3. Radiological and clinical assessment
The anatomical level of the spinal anomaly was thoracic in 7 (19.4%), lumbar 
in 27 (75.0%), and sacral in 2 (5.6%) infants (Table 1). Motor impairment level 
was assessed as thoracic in 12 infants (33.3%), lumbar in 16 infants (44.3%), and 
sacral in 8 infants (22.2%). The neonatal sensory impairment level was assessed 
as thoracic in 7 infants (19.4%), lumbar in 18 infants (50.0%), and sacral in 11 
infants (30.6%). 
Table 1. Patients characteristics
n
Type of spina bifida
Open anomaly 33
Closed anomaly 3
Cerebral comorbidity
Hydrocephalus 30
Chiari II malformation 31
Corpus callosum dysgenesis 28
Anatomical level of defect
Thoracic 7
Lumbar 27
Sacral 2
Level of motor impairment
Thoracic 12
Lumbar 16
Sacral 8
Level of sensory impairment
Thoracic 7
Lumbar 18
Sacral 11
n, number of patients
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3.3.1. Associations between neurophysiological measures and radiological or 
clinical assessment 
The associations between the neurophysiological measures and neonatal clinical 
assessment are shown in Table 4. Lower levels of neonatal motor and sensory 
impairment were statistically significantly associated with larger GC MEP areas 
and CMAP areas, whereas these associations were slightly weaker for the quad-
riceps femoris muscle and the TA MEP areas. Especially for sensory impairment, a 
cranio-caudal gradient was demonstrated for the MEP area: the more cranial the 
neurosegmental innervation of the muscle, the weaker the association seems to 
be. No meaningful associations were found between the latencies and motor or 
sensory impairment, nor between any of the MEP or CMAP parameters and the 
anatomical level of the spinal anomaly.
3.3.2. Associations between neurophysiological or clinical measures and 
outcomes 
The associations between the MEP and CMAP areas assessed after birth and 
Muscle Function Classes and ambulation groups at 2 years of age are shown in 
Table 2. Motor evoked potentials after lumbar magnetic stimulation
Muscle
Latency (ms) MEP area (mVms)
nMedian Range Median Range
QF right 5.0 2.8-8.2 1.8 0.1-16.6 32
QF left 4.9 3.4-10.7 2.3 0.1-19.8 32
TA right 8.2 5.6-11.4 1.2 0.1-19.7 29
TA left 8.6 4.9-11.4 1.3 0.1-19.9 31
GC right 8.3 6.3-12.4 2.1 0.1-20.7 19
GC left 9.2 7.1-12.5 1.6 0.1-20.9 19
QF, quadriceps femoris muscle ; TA, tibialis anterior muscle ; GC, gastrocnemius muscle.
Table 3. Compound muscle action potential after percutaneous electrical nerve stimula-
tion
Muscle
Latency (ms) CMAP area (mVms)
nMedian Range Median Range
TA right 2.6 1.8-5.8 6.7 0.3-19.4 31
TA left 2.6 1.8-5.5 4.7 0.2-19.5 31
GC right 3.3 2.5-4.5 4.0 0.0-26.6 19
GC left 3.1 2.1-5.0 3.6 0.0-26.7 20
TA, tibialis anterior muscle; GC, gastrocnemius muscle; n, number of patients
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Table 5. Five children (13.9%) died before the age of 2 years and 2 (5.6 %) children 
were lost to follow up due to emigration. The remaining 29 children were further 
examined. Three children were assigned to Muscle Function Class I (10.3%), 4 
to MFC II (13.8%), 9 tot MFC III (31.0%), 8 to MFC IV (27.6%) and 5 tot MFC V 
(17.2%). From the 29 children, 9 (31.0%) were community ambulators, 4 (13.8%) 
were household ambulators and 16 (55.2%) were non-functional ambulators at 
the age of 2 years.
Lower neonatal impairment levels were seen in the mildly impaired subgroups 
compared to the severely impaired subgroups for both MFC and ambulation. For 
the TA and GC MEP areas, the difference between mildly impaired and severely 
impaired MFC subgroups of children approached statistical significance.
The CMAP areas were statistically significantly larger for the mildly impaired com-
pared to the severely impaired children (p = 0.03). All MEP and CMAP areas were 
larger for the community ambulators compared to the non-community ambula-
tors, but these differences did not reach statistical significance. The latencies did 
not differ between the outcome measure subgroups (data not shown).
Table 4. Spearman rank correlation coefficients (r) of MEP and CMAP parameters with 
neonatal neurological impairment and level of the spinal anomaly
Motor 
impairment
Sensory 
impairment
Level of the 
spinal anomaly
n
r p-value r p-value r p-value n
MEP area
Quadriceps femoris -0.31 0.09 -0.26 -0.16 -0.02 0.90 32
Tibialis anterior -0.31 0.10 -0.39 -0.04 -0.01 0.96 29
Gastrocnemius -0.66 0.00 -0.60 -0.01 -0.18 0.48 19
MEP latency
Quadriceps femoris -0.10 0.60 -0.11 0.56 -0.10 0.60 32
Tibialis anterior -0.05 0.78 -0.13 0.50 0.24 0.21 29
Gastrocnemius -0.24 0.33 -0.12 0.62 0.20 0.42 19
CMAP area
Tibialis anterior 0.54 0.00 0.43 0.02 0.14 0.46 31
Gastrocnemius 0.79 0.00 0.56 0.01 0.13 0.61 19
CMAP latency
Tibialis anterior -0.34 0.06 -0.12 0.52 -0.22 0.24 31
Gastrocnemius -0.26 0.28 -0.37 0.12 0.02 0.95 19
p-values < 0.05 are indicated in italics; n, number of patients
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4. Discussion
This study is the first to evaluate the prognostic value of MEP and CMAP record-
ings for infants with spina bifida, assuming that MEPs and CMAPs may provide 
additional information about neonatal neurological impairment of the lower limb 
muscles. The study showed associations between the MEPs and neonatal neuro-
logical impairment in newborn infants with spina bifida. The magnitudes of the 
MEP in the lower limb muscles, represented by the area under the curve of the first 
negative wave, related to the levels of motor and sensory impairment. The levels 
of impairment were also associated with the CMAP areas under the curve. The 
results on spinal magnetic stimulation have not been reported before. Findings on 
associations between the CMAP after percutaneous electrical nerve stimulation 
and neurological impairment in newborn infants with spina bifida have previously 
been described for a smaller group of patients.21 Other authors also reported re-
Table 5. Neonatal neurophysiological measurements and clinical impairment (median 
values) in relation to the outcome at two years of age
Muscle function class p-valuec Community 
ambulator
p-valuec
Milda Severeb Yes No
(n = 7) (n = 22) (n = 9) (n = 20)
MEP area
Quadriceps femoris 2.7 2.1 0.83 3.6 1.6 0.23
Tibialis anterior 4.9 1.1 0.05 1.4 1.0 0.45
Gastrocnemius 2.5 1.8 0.15 2.5 1.6 0.44
CMAP area
Tibialis anterior 8.7 4.3 0.03 8.1 4.3 0.15
Gastrocnemius 11.5 3.8 0.03 8.1 2.2 0.10
Clinical impairment
Motor impairment 18.0 14.5 0.00 18.0 13.5 0.00
Sensory impairment 19.0 15.0 0.00 17.0 14.0 0.01
Level of the spinal anomaly 15.0 14.0 0.12 15.0 13.5 0.03
p-values < 0.05 are indicated in italics
a Mildly impaired according to muscle function class I and II
b Severely impaired according to muscle function class III-V
c p-value based on Mann Whitney U test
n, number of patients; these numbers are meant for the group in total and may be slightly different for 
the specific muscles assessed.
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sponses to be present in lower limb muscles in almost all infants with spina bifida, 
although they used other methods of stimulation, such as electrical neural plaque 
stimulation and faradic muscle stimulation28 in addition to percutaneous electrical 
nerve stimulation.13 In these studies, only the presence or absence of a response 
was evaluated in relation to clinical impairment. This cannot be a diagnostic cri-
terion, however, when responses are present in virtually every infant. In contrast, 
the associations found between the MEP and CMAP areas and neurological impair-
ment in our study showed that these areas provide additional information about 
the degree of neurological impairment.
The latencies did not relate to neurological impairment, probably because the 
ranges of the latency values were relatively small (Tables 2 and 3). The MEP laten-
cies in the quadriceps femoris muscle were shorter than the MEP latencies in the 
other muscles, which is in accordance with the difference in distances from the 
point of excitation to the site of recording. 
A possible disadvantage of spinal magnetic stimulation is temporal dispersion.23 24 
However, as the MEP area is less liable to temporal dispersion than the amplitude, 
the area under the first negative curve was used as measure for the magnitude 
of the MEP. Other possible disadvantages of spinal magnetic stimulation are dif-
ficulty in obtaining maximal responses and the fact that the magnitude of the MEP 
depends on the stimulus site and the thickness of the intervening tissue between 
the coil and the motor neurons.29 Maegaki et al 30 suggest that the structure of 
the vertebral bone surrounding the nerve roots plays an important role and may 
interfere with the spread of magnetically induced currents. In children with spina 
bifida, all of the structures surrounding the spinal cord may be involved in the 
congenital malformation and this may interfere with the magnetic currents. Per-
cutaneous electrical nerve stimulation was performed only for the tibialis anterior 
and gastrocnemius muscles. It would have been interestingly to perform electrical 
stimulation of the femoral nerve as well. However, this may be technically difficult 
as all infants had to be assessed in prone position in an incubator, because of the 
spinal anomalies. As such, femoral nerve stimulating would have resulted in unreli-
able responses. Besides, electrical stimulation of the femoral nerve may be too 
painful in infants. Despite these limitations, clear associations were found between 
the magnitudes of the MEPs and CMAPs and neonatal neurological impairment. 
The results on sensory and motor impairment reflect the neurosegmental inner-
vation of the muscles studied: the more cranial the neurosegmental innervation 
of the muscle, the weaker the association between the MEP area and sensory or 
71
Chapter 5 | M
EPs and CM
A
Ps
motor impairment. These results are compatible with the results on the CMAPs 
after percutaneous electrical nerve stimulation.
The results on motor impairment reflect strong associations with the MEP areas 
and CMAP areas of the gastrocnemius muscles and the CMAP areas of the tibialis 
anterior muscle, but no statistically significant correlations with the MEP areas 
of the tibialis anterior and quadriceps femoris muscles. Furthermore, the MEPs 
and CMAPs of the gastrocnemius and tibialis anterior seem to be of prognostic 
value for motor development towards ambulation at two years of age. We found 
a statistically significant difference in the CMAP areas of the tibialis anterior and 
gastrocnemius muscles and the MEP areas of the tibialis anterior muscle between 
MFC subgroups which are indicative of ambulation later in life. As walking might 
be delayed in children with spina bifida, some children will eventually become com-
munity ambulators at the age of 6 years.31 This might explain why we did not find 
clear differences for the MEPs and CMAPs between the ambulation groups at the 
relative early age of 24 months. Muscle Function Class was dichotomized into two 
groups, and this may explain the lack of a difference in MEP areas of the quadriceps 
femoris muscle, as both children in MFC I and II (group 1 in our analysis) and chil-
dren in MFC III (part of group 2 in our analysis) need good knee extension. 
In this study, clinical parameters, such as motor and sensory impairment level 
showed strong associations with MFC group and ambulation status. To what 
extent MEPs and CMAPs are as accurate as neonatal clinical neurological examina-
tions and whether they have added prognostic value for ambulation - reached at 
a later age than 2 years old - requires further study. Important in this respect are 
the quality of the neurological examination on one hand and the skill level of the 
assessor performing the neurophysiologic assessment on the other hand.
Conclusion
Clinical determination of neurological impairment in newborn infants with spina 
bifida is complex. The demarcation of impairment to spinal segments is a simpli-
fication of the actual impairment, because residual motor function is present in 
affected spinal segments caudally from this demarcation. The use of MEPs and 
CMAPs might be a useful method to assess this residual function. Although these 
methods have their limitations, the present study showed that MEPs after spinal 
magnetic stimulation and CMAPs after percutaneous electrical nerve stimulation 
are reliable additional tools in the clinical evaluation of infants with spina bifida. As 
such, they may be valuable in complex cases and research settings where objective 
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information might be needed concerning neurological impairment in addition to 
clinical evaluation.
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ABSTRACT 
We aimed to disentangle the proportional contribution of upper and lower mo-
tor neuron dysfunction to motor impairment in children with spina bifida. We 
enrolled 42 children (mean age, 11.2 years; standard deviation, 2.8 years) with 
spina bifida and 36 control children (mean age, 11.4 years; standard deviation, 
2.6 years). Motor impairment was graded to severity scales in children with spina 
bifida. We recorded motor evoked potentials after transcranial and lumbosacral 
magnetic stimulation and compound motor action potentials after electric nerve 
stimulation. Regarding lower motor neuron function, severely impaired children 
with spina bifida demonstrated smaller compound muscle action potential areas 
and lumbosacral motor evoked potential areas than control children; mildly im-
paired children hardly differed from control children. Compound muscle action 
potential latencies and lumbosacral motor evoked potential latencies did not differ 
between children with spina bifida and control children. Regarding upper motor 
neuron function, children with spina bifida demonstrated smaller transcranial mo-
tor evoked potential areas and longer central motor conduction times than control 
children. The smallest motor evoked potential areas and longest central motor 
conduction times were observed in severely impaired children. In children with 
spina bifida, the contribution of upper motor neuron dysfunction to motor impair-
ment is more considerable than expected from clinical neurologic examination. 
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Introduction
Spina bifida is a complex congenital malformation of the nervous system in which 
lower limb motor impairment may result from lower motor neuron and upper 
motor neuron dysfunction. Lower motor neuron dysfunction directly results from 
segmental disorders in the spinal anomaly. Upper motor neuron dysfunction, 
however, may result from disorders of the corticospinal tract, either in or above 
the spinal anomaly. Disorders above the spinal anomaly include Chiari II malforma-
tion and white matter [1,2] and gray matter [3,4] abnormalities, whether or not 
they are related to hydrocephalus. Given the complex neuropathology, knowledge 
about the proportional contribution of lower and upper motor neuron dysfunc-
tion to lower limb motor impairment is limited. However, when choices about 
treatment opportunities, such as prenatal surgery, are necessary, it is essential to 
distinguish corticospinal from spinal motor dysfunction in spina bifida. 
In prenatal surgery, secondary damage to neural tissue may be prevented by cover-
ing the spinal anomaly at an early gestational age [5,6]. A randomized, controlled 
trial demonstrated improvements in motor outcome and reductions of hindbrain 
herniation and hydrocephalus shunting after prenatal surgery compared with post-
natal surgery [7]. These important improvements at more than one level along 
the neural axis may be associated with corticospinal and spinal motor function 
improvement. 
Distinguishing upper from lower motor neuron dysfunction in neurologic examina-
tion is difficult, because predominant flaccid paresis may mask upper motor neuron 
involvement. Traditionally, the level of motor impairment is classified according to 
the segmental innervation scheme of Sharrad [8], but for prognostic purposes, 
the use of specific patterns of muscle strength seems to be more robust [9,10]. 
Although upper motor neuron signs are important in predicting outcomes [11], 
classifications do not differentiate between upper and lower motor neuron dys-
function.
Motor evoked potentials after magnetic stimulation are particularly useful for in-
vestigating upper and lower motor neuron dysfunction, and are of diagnostic value 
in several neurologic disorders in adults and children [12,13]. They constitute a safe 
and noninvasive method that is easily used and well tolerated [14,15]. Transcranial 
magnetic stimulation provides information about cortical motor function and the 
integrity of the corticospinal tract, whereas lumbosacral magnetic stimulation and 
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nerve conduction studies, among others, by means of compound motor action 
potential recording, provide information about spinal motor function [16].
The present study sought to disentangle the proportional contribution of upper 
and lower motor neuron dysfunction to lower limb motor impairment in children 
with spina bifida. We hypothesized that clinically hidden upper motor neuron 
dysfunction could be revealed using transcranial magnetic stimulation.
Methods
Participants
Children with spina bifida were recruited from the Outpatient Clinic of Pediatric 
Neurology at the Radboud University Nijmegen Medical Center in the Netherlands 
(Nijmegen, the Netherlands). Inclusion criteria comprised (1) birth between Janu-
ary 1988 and December 1997, and (2) the presence of an open spinal dysraphism, 
such as myelomeningocele or myelocele, or a closed spinal dysraphism with a 
subcutaneous mass, such as lipomyelocele, lipomyelomeningocele, or meningocele 
[17], as assessed by neonatal physical examination and magnetic resonance imag-
ing in the context of a larger research project, and classified according to Rossi et 
al.[17]. Exclusion criteria comprised (1) the presence of closed dysraphic states 
without a subcutaneous mass, such as intradural lipoma, tight filum terminale, 
dermal sinus or diastematomyelia [17]; and  (2) additional congenital malforma-
tions, except for cerebral malformations that are commonly associated with spinal 
dysraphism, such as hydrocephalus, Chiari II malformations, and corpus callosum 
dysmorphology.
Control children were recruited from the Outpatient Clinics of General Pediatrics, 
Pediatric Surgery, and Pediatric Orthopedics at the Radboud University Nijmegen 
Medical Center. Inclusion criteria comprised (1) good health and physical condi-
tion, and (2) transient disease with complete recovery. Exclusion criteria com-
prised (1) the suspicion or presence of neurologic abnormalities, developmental 
delay, or behavioral disorder, as ascertained from chart review, interview, and 
complete neurologic examination, and (2) chronic disease. The Regional Commit-
tee on Research Involving Human Subjects approved the study design. Written 
informed consent was obtained from parents of all participating children, and from 
all children above 12 years of age.
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Clinical evaluation
We used three measures to assess lower limb motor function: muscle strength, 
muscle function class, and ambulation. Muscle strength was graded bilaterally on 
a scale of 0-5 by manual muscle testing [18]. The muscle strengths of the quad-
riceps femoris muscle, tibialis anterior muscle, and gastrocnemius muscle were 
analyzed as separate variables. Muscle function classes were defined according to 
patterns of muscle strength [9,10], i.e., 0, no weakness in any lower limb muscle; 
1, weakness of intrinsic foot muscles; 2, weakness or absence of plantar flexion; 3, 
weakness or absence of knee flexion; 4, weakness or absence of knee extension; 
and 5, no muscle activity in the lower limbs. Ambulation was classified according 
to modified criteria of Hoffer et al. [10,19] into: 1, community ambulation; 2, 
community ambulation with wheelchair use only for long distances outdoors; 3, 
household ambulation with wheelchair use outdoors only; 4, household ambula-
tion with wheelchair use indoors and outdoors; and 5, nonfunctional ambulation. 
In addition, the spinal anomaly and the presence of Chiari II malformations, hydro-
cephalus, or callosal dysgenesis were assessed by magnetic resonance imaging (1.5 
T magnetic resonance imaging unit, Siemens Avanto, Siemens Medical Solutions, 
Erlangen, Germany).
Neurophysiological assessment
The children with spina bifida and the control children without spina bifida under-
went the same neurophysiologic investigations. All children were sitting on a chair 
or lying on a couch while motor evoked potentials and compound muscle action 
potentials were recorded using surface electrodes (standard tendon-belly mon-
tage) and an Oxford Synergy Electromyograph (Oxford  Instruments, Old Woking, 
Surrey, United Kingdom; band-pass filter, 20 Hz and 3 kHz; amplifier range, 100 
mV; and display sensitivity 0.5 mV/division). We obtained motor evoked potentials 
bilaterally from the quadriceps femoris, tibialis anterior, gastrocnemius, and biceps 
brachii muscles, and compound muscle action potentials from the tibialis anterior 
and gastrocnemius muscles.
For magnetic stimulation, a monophasic stimulator (Magstim 200, The Magstim 
Co., Ltd., United Kingdom) was used. Transcranial magnetic stimulation was per-
formed at 100% stimulation intensity, with a double 110-mm cone coil positioned 
centrally over the vertex to record motor evoked potentials from the lower limb 
muscles, and with a 90-mm circular coil positioned centrally over the vertex to 
record motor evoked potentials from the biceps brachii musle. Unfacilitated motor 
evoked potentials were recorded during relaxation of the target muscle, and facili-
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tated motor evoked potentials during active isometric contraction of the target 
muscle against manual resistance. If children with spina bifida were not able to 
perform a contraction, we asked them to pretend they were performing a contrac-
tion. This strategy will also result in facilitated motor evoked potentials [16]. 
Spinal magnetic stimulation was performed with a 90-mm circular coil positioned 
centrally over the spine. In all children, cervical magnetic stimulation was per-
formed over C7 to record motor evoked potentials from the biceps brachii muscle. 
In control children, lumbosacral stimulation was performed at L5 for the quadriceps 
femoris muscle and S1 for the tibialis anterior and gastrocnemius muscles, where 
we expected the largest motor evoked potentials [20]. Because of the abnormal 
anatomy of the spine, lumbosacral stimulation was performed successively at 
four levels (L4, L5, S1, and S2) to search for the largest motor evoked potential 
in children with spina bifida. This motor evoked potential was then used in the 
analyses. Stimulation intensity was measured at 100% in all children, except for a 
few control children in whom this intensity led to discomfort. In these children, we 
used stimulation intensities of 80% or 90%. No substantial response differences 
were expected at intensities ranging from 80% to 100% [21].
In addition, percutaneous electrical stimulation of the peroneal nerve and the 
posterior tibial nerve was performed at the popliteal fossa to assess the maximal 
compound muscle action potential in the tibialis anterior and gastrocnemius 
muscles, respectively.
For each motor evoked potential and compound muscle action potential, the onset 
latency (ms) and the area under the curve of the first negative wave (mVms) were 
calculated. For each target muscle, the central motor conduction time (ms) was 
calculated from the difference between the onset latency of the facilitated tran-
scranial motor evoked potential and the onset latency of the spinal motor evoked 
potential.
During our investigation, children were observed for discomfort by an independent 
observer. In case of discomfort, we terminated the investigation prematurely.
Statistical analysis
Three clinical measures were analyzed as dichotomized variables, resulting in a 
mildly and a severely impaired subgroup for each measure: muscle strength 0-3 
(weakness) versus 4-5 (no or little weakness); muscle function class of 0-2 (ex-
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pected to be ambulant) versus 3-5 (expected not to be ambulant); and ambula-
tion of 1-2 (community ambulant) versus 3-5 (noncommunity ambulant).
Because the neurophysiologic data were not normally distributed, we used non-
parametric tests. The Mann-Whitney U test was used to study differences in neu-
rophysiologic parameters between children with spina bifida and control children, 
and between mildly and severely impaired children with spina bifida. Differences 
between unfacilitated and facilitated motor evoked potentials were analyzed using 
the Wilcoxon test for paired observations. P < 0.05 was considered statistically 
significant. 
Results
Participants
Forty-two children (16 boys and 26 girls) with spina bifida were enrolled in the 
study. Twenty-six children manifested open spinal dysraphism, and 16 manifested 
closed spinal dysraphism with a subcutaneous mass. The level of the spinal anomaly 
was thoracic in nine, lumbar in thirty-one, and sacral in two children. Twenty-four 
children manifested hydrocephalus, 23 manifested Chiari II malformation, and 18 
manifested callosal dysgenesis. The mean age ± standard deviation was 11.2 ± 2.8 
years (range, 6.5-16.8 years). All children had undergone neonatal spinal surgery, 
and all children with hydrocephalus were shunted within their first month of age. 
At the moment of investigation, none of the children presented with signs of shunt 
malfunction. 
Thirty-six control children (13 boys and 23 girls) were enrolled in the study. The 
mean age ± standard deviation was 11.4 ± 2.6 years (range, 6.1-15.8 years). 
Clinical evaluation
Lower limb motor function in the children with spina bifida was assessed by three 
clinical measures: muscle strength, muscle function class, and ambulation. Regard-
ing muscle strength, nine children demonstrated weakness (grade 0-3 on manual 
muscle testing) of the quadriceps femoris muscles, 18 of the tibialis anterior 
muscles, and 20 of the gastrocnemius muscles. Muscle function classes 0-2 applied 
to 29 children, and muscle function classes 3-5 applied to 13 children. Regarding 
ambulation, 25 children were community ambulant, and 17 were noncommunity 
ambulant. In our description of the results for upper and lower motor function, the 
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subgroups based on these three clinical measures will be referred to as mildly or 
severely impaired. 
Recorded motor evoked potentials and compound muscle action potentials
In a few children with spina bifida, the measurements were incomplete because of 
premature termination of the investigation upon discomfort, or else transcranial 
or spinal magnetic stimulation did not result in motor evoked potentials. As such, 
the number of available motor evoked potentials per target muscle ranged from 
23-34 after transcranial magnetic stimulation, and from 34-38 after spinal mag-
netic stimulation. Compound muscle action potentials in the tibialis anterior and 
gastrocnemius muscles were available for 40 and 36 children with spina bifida, 
respectively. In 12 control children, the measurements were incomplete because 
of premature termination. In the remaining control children, all responses were ob-
tained. The number of available motor evoked potentials per target muscle ranged 
from 24-30 after transcranial magnetic stimulation, and from 29-31 after spinal 
magnetic stimulation. Compound muscle action potentials in the tibialis anterior 
and gastrocnemius muscles were available for 30 control children for each muscle.
Lower motor neuron function 
Compound muscle action potentials and lumbosacral motor evoked potentials 
provide information about lower motor neuron function. Areas of compound 
muscle action potential (i.e., areas under the curve of the first negative wave of 
a compound muscle action potential) were smaller in children with spina bifida 
than in control children. Among children with spina bifida, areas of  compound 
muscle action potential were smallest in severely impaired children, whereas mildly 
impaired children differed from control children only for areas of gastrocnemius 
compound muscle action potential (Table 1 and Figure 1). 
Results for areas of lumbosacral motor evoked potential in the quadriceps femo-
ris muscle were similar to the results for the areas of compound muscle action 
potential. Areas of lumbosacral motor evoked potential were smaller in children 
with spina bifida than in control children, except for the tibialis anterior muscle. 
Among children with spina bifida, areas of motor evoked potential were smallest in 
severely impaired children, whereas mildly impaired children differed slightly from 
control children (Table 2 and Figure 1). 
Latencies of compound muscle action potential and lumbosacral motor evoked 
potential did not differ between children with spina bifida and control children. 
Among children with spina bifida, latencies of compound muscle action potential 
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were longest in severely impaired children, whereas latencies of lumbosacral mo-
tor evoked potential did not differ between mildly and severely impaired children 
(Tables 1 and 2, and Figure 1). 
Upper motor neuron function
Transcranial motor evoked potentials and central motor conduction times provide 
information about upper motor neuron function. Areas of facilitated transcranial 
motor evoked potentials were smaller in children with spina bifida than in control 
children for the lower limb muscles, as well as for the upper limb muscles. Areas 
of motor evoked potentials were smallest in severely impaired children, whereas 
mildly impaired children still demonstrated substantially smaller areas of motor 
evoked potential than did control children (Table 3 and Figure 2). 
We observed similar results for latencies of facilitated motor evoked potentials, 
i.e., longer latencies in children with spina bifida compared with control children, 
and in severely impaired children compared with mildly impaired children (data not 
shown). In contrast, areas and latencies of unfacilitated transcranial motor evoked 
Table 1. Compound Muscle Action Potential area and latency (median values) in control 
children and children with spina bifida
 
Area (mVms)
 
Latency (ms)
TA P Value*   GM P value TA P value   GM P Value
Children with spina bifida versus control children
 Control 12.2 21.2 2.9 3.3
 Spina bifida 7.5 <0.01  8.3 <0.01 2.7 0.30 3.1 <0.12
Among children with spina bifida
 Muscle strength in target muscle 
 No or little weakness (4-5) 10.9 9.8 2.5 2.8
 Weakness (0-3) 4.3   <0.01 6.8 <0.07 3.1 <0.02 3.5 <0.01
 Muscle function class
 Class 0-2 10.5 9.2 2.5 2.8
 Class 3-5 3.3 <0.01 6.7 <0.03 3.3 <0.01 3.5 <0.05
 Ambulation
 Community ambulation 10.5 9.2 2.6 2.8
 Noncommunity ambulation 5.2 <0.01 6.7 <0.07 3.1 <0.04 3.5 <0.08
Abbreviations:   
GM = Gastrocnemius muscle
TA = Tibialis anterior muscle
*P value based on the Mann-Whitney U test
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potentials did not differ between children with spina bifida and control children, 
or among children with spina bifida. Hence, areas of facilitated motor evoked po-
tentials were larger than areas of unfacilitated motor evoked potentials in control 
Figure 1. Box plots indicate compound muscle action potential (CMAP) area (A), compound 
muscle action potential latency (B), lumbosacral motor evoked potential (MEP) area (C), 
and lumbosacral motor evoked potential latency (D) in lower limb muscles in control chil-
dren and in children with spina bifida grouped according to muscle strength in the tar-
get muscles. Bold horizontal lines indicate median values; boxes represent interquartile 
ranges (IQR), vertical lines represent 1.5 IQR, and separate points comprise outliers. QF, 
quadriceps femoris muscle; TA, tibialis anterior muscle; GM, gastrocnemius muscle.
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children and mildly impaired children with spina bifida, but not in severely impaired 
children. This result is illustrated according to muscle function class in Figure 2. 
Central motor conduction times were longer in children with spina bifida than 
in control children for lower limb muscles as well as for the upper limb muscles. 
Central motor conduction times were longer in severely impaired compared with 
mildly impaired children, although this result was not  statistically significant for all 
muscles, whereas mildly impaired children still demonstrated longer central motor 
conduction times than did control children (Table 4 and Figure 3).
Table 3. MEP area (mVms; median values) of facilitated transcranial MEPs in control chil-
dren and children with spina bifida
Area (mVms) Latency (ms)
QF P Value* TA P Value GM P Value BB P Value
Children with spina bifida vs control children
 Control 16.6 8.4 7.0 23.2
 Spina bifida 7.1 <0.01 4.2 <0.02 2.9 <0.01 7.0 <0.01
Among children with spina bifida
 Muscle strength target muscle
 No or little weakness (4-5) 9.0 5.3 3.1
 Weakness (0-3) 1.0 <0.01 1.4 <0.03 1.5 <0.38
 Muscle function class
 Class 0-2 10.5 5.2 3.7 8.8
 Class 3-5 1.7 <0.01 1.4 <0.02 0.7 <0.02 5.0 <0.12
 Ambulation
 Community ambulation 10.7 5.2 4.1 8.1
 Noncommunity ambulation 1.9 <0.01 1.4 <0.01 0.8 <0.01 5.7 <0.35
Abbreviations:
BB = Biceps brachii muscle 
GM = Gastrocnemius muscle
MEP = Motor evoked potential
QF = Quadriceps femoris muscle
TA = Tibialis anterior muscle
* P values were based on Mann-Whitney U test.
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Discussion
Spina bifida is a congenital malformation of the nervous system with complex 
neuropathology involving corticospinal and spinal motor pathways. In an at-
tempt to disentangle upper motor neuron involvement from lower motor neuron 
involvement in lower limb motor impairment, this study demonstrated upper mo-
tor neuron dysfunction in both mildly and severely impaired children with spina 
bifida, whereas lower motor neuron dysfunction was mainly observed in severely 
impaired children.
Figure 2. Box plots indicate differences between facilitated and unfacilitated transcranial 
Motor evoked potential (MEP) areas in control children, and in mildly impaired children 
(MFC 0-2) and severely impaired children (MFC 3-5) with spina bifida for four muscles: the 
biceps brachii muscle (A), quadriceps femoris muscle (B), tibialis anterior muscle (C), and 
gastrocnemius muscle (D). Bold horizontal lines indicate median values; boxes represent 
interquartile ranges (IQR), vertical lines represent 1.5 IQR, and separate points comprese 
outliers. MFC, muscle function class.
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Upper motor neuron dysfunction was identified by reduced areas of transcranial 
motor evoked potentials and prolonged central motor conduction times. The tran-
scranial motor evoked potential may also reflect lower motor neuron dysfunction, 
but the central motor conduction time above all reflects upper motor neuron 
dysfunction. The degree of upper motor neuron dysfunction seemed to be associ-
ated with the severity of clinical motor impairment. Moreover, the central motor 
conduction times resembled the different neurosegmental innervations of the 
investigated muscles. In the complex neuropathology of spina bifida, the origin of 
upper motor neuron dysfunction may occur in the corticospinal tract in or above 
the spinal anomaly. Because the results were similar for both upper and lower limb 
muscles, we considered upper motor neuron dysfunction to be located above the 
spinal anomaly, or to be more specific, above the neurosegmental innervation of 
the biceps brachii. The dysfunction at this location may result from damage to the 
corticospinal tract at the cervicomedullary junction because of hindbrain hernia-
tion or from white matter abnormalities, whether related to hydrocephalus or not. 
This explanation may be supported by diffusion tensor imaging studies revealing 
complex white matter abnormalities in spina bifida [1].
Figure 3. Box plots indicate differences in central motor conduction time (CMCT) between 
control children and mildly impaired children (MFC 0-2) and severely impaired children 
(MFC 3-5) with spina bifida. Bold horizontal lines indicate median values; boxes represent 
interquartile ranges (IQR), vertical lines represent 1.5 IQR, and separate points are outliers. 
MFC, muscle function class; BB, biceps brachii muscle; QF, quadriceps femoris muscle; TA, 
tibialis anterior muscle; GM, gastrocnemius muscle.
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As observed in the control children, voluntary muscle contraction during transcra-
nial magnetic stimulation resulted in shorter latencies of motor evoked potentials 
and larger areas of motor evoked potentials [22]. This facilitation was substantially 
decreased in children with spina bifida (Figure 2). Although the physiology of fa-
cilitation is not entirely understood, changes in both spinal and cortical excitability 
seem to be involved [23]. Based on our results, it difficult to deduce whether 
abnormalities in spinal or cortical excitability are responsible for the decreased 
facilitation. Remarkably, even in muscles with no or little weakness (i.e., children 
were able to perform a contraction of at least Medical Research Council scale 
grade 4) and with substantial compound muscle action potentials, facilitated mo-
tor evoked potentials were smaller than in control muscles. Therefore, the simple 
explanation that the inability to perform a muscle contraction results in smaller 
facilitated motor evoked potentials is not applicable. We suggest that abnormal 
cortical excitability is responsible for decreased facilitation in spina bifida. 
Table 4. Central motor conduction time (in milliseconds, with median values) in control 
children and children with spina bifida
  QF P Value* TA P Value GM P Value BB P Value
Children with spina bifida vs control children
Control 11.1 12.1 14.6 4.6
Spina bifida 12.7 <0.01 16.1 <0.01 16.4 <0.02 5.6 <0.01
Among children with spina bifida
 Muscle strength target muscle
 No or little weakness (4-5) 12.5 15.1 15.7
 Weakness (0-3) 14.9 <0.53 21.5 <0.01 19.4 <0.04
 Muscle function class
 Class 0-2 12.4 15.3 16.2 5.3
 Class 3-5 15.0 <0.09 21.7 <0.03 19.4 <0.32 6.8 <0.01
 Ambulation
 Community ambulation 12.7 15.3 16.4 5.2
 Noncommunity ambulation 13.6 <0.63 21.7 <0.03 17.3 <0.57 6.6 <0.07
Abbreviations:
BB  = Biceps brachii muscle
GM  = Gastrocnemius muscle
QF  = Quadriceps femoris muscle
TA  = Tibialis anterior muscle
*P values were based on Mann-Whitney U test.
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Lower motor neuron dysfunction can be identified from compound motor action 
potentials and lumbosacral motor evoked potentials. Areas of compound motor 
action potentials and lumbosacral motor evoked potentials were reduced only in 
severely impaired children with spina bifida, whereas latencies were unaffected in 
both mildly and severely impaired children. Therefore, the number of motor units 
may be reduced because of axonal loss, particularly in severely impaired children, 
whereas the conductive ability of the preserved motor units seems to be relatively 
intact. Moreover, compound muscle action potentials and lumbosacral motor 
evoked potentials were still obtainable in clinically paralytic muscles. These results 
are compatible with previously reports of lower motor neuron function in newborn 
infants with spina bifida [24,25].
The differentiation into upper and lower motor neuron dysfunction is scarcely 
addressed in reports on neurological outcomes of spina bifida. In observational 
studies of newborn infants, the disappearance of lower limb movements has been 
related to lower motor neuron dysfunction, whereas neural conduction through 
the spinal anomaly was related to preserved upper motor neuron function [26]. 
Although we investigated older children, our results are in slight contrast with 
those previous results, because upper motor neuron dysfunction was more obvi-
ously involved in motor impairment, whereas lower motor neuron function seems 
to be relatively preserved throughout childhood. We hypothesize that lower mo-
tor neuron dysfunction is secondary to upper motor neuron dysfunction, because 
the upper motor neuron is involved in the activity-dependent regulation of the 
development of the LMN [27].
These findings may involve consequences for clinical practice. Although flaccid 
paresis is generally the most prominent clinical sign, lower motor neuron dysfunc-
tion may play a minor role in motor impairment. Upper motor neuron dysfunction, 
on the other hand, although it is masked by flaccid paresis, seems to contribute 
considerably to motor impairment. Our results also indicate that upper motor neu-
ron dysfunction is related to functional outcome, because the ability to walk was 
associated with the degree of upper motor neuron dysfunction. Moreover, upper 
motor neuron dysfunction should be considered in cases of unexplained deteriora-
tion of function. For example, secondary tethering of the spinal cord is commonly 
observerd in growing children with spina bifida, and is generally associated with 
additional upper motor neuron dysfunction. Transcranial magnetic stimulation 
may be helpful in early recognition of this complication.
93
Chapter 6 | Corti
cal Spinal Tract
Furthermore, transcranial magnetic stimulation may provide objective information 
about corticospinal and spinal motor function in research settings, with particular 
relevance for the outcomes of prenatal surgery for spina bifida. Prenatal surgery 
shows promise for improvement in motor function and reductions of hindbrain 
herniation and hydrocephalus shunting [7].  Using transcranial magnetic stimula-
tion, improvements in upper and lower motor neuron function in relation to the 
reported clinical and morphologic improvements may be revealed. 
The study contains some limitations: (1) Because of our cross-sectional design, the 
study group was heterogeneous. In our neurophysiologic results, we did not differ-
entiate between open and closed spinal dysraphism, or between the presence and 
absence of cerebral co-morbidity, because we were primarily interested in lower 
limb motor impairment in relation to upper and lower motor neuron dysfunction. 
(2) The level of lumbosacral magnetic stimulation differed between children with 
spina bifida and control children. Performing lumbosacral stimulation at one level 
does not make sense in children with spina bifida, because of the abnormal anat-
omy of the spine and spinal cord. Nevertheless, abnormal anatomy may have had 
some influence on the results of lumbosacral stimulation. (3) We estimated central 
motor conduction times according to the difference between the latencies of the 
transcranial motor evoked potential and the lumbosacral motor evoked potential. 
Using this method, the calculated central motor conduction times includes a small 
part of the proximal lower motor neuron, because lumbosacral magnetic stimula-
tion results in the activation of motor nerve roots at the site where they leave the 
intervertebral foramen [20,28]. However, considering the unaffected latency of 
lumbosacral motor evoked potentials in children with spina bifida, the part of the 
proximal lower motor neuron included will be equal for children with spina bifida 
and control children. Therefore, the differences in central motor conduction times 
primarily reflect a difference in corticospinal motor conduction between children 
with spina bifida and control children. (4) In some children, the study protocol was 
incompletely applied. However, a sufficient number of responses were available for 
analyses. In children with spina bifida, a few muscles were unresponsive. We did 
not use these results in our analyses, because they would have rendered the differ-
ences with the control children unjustifiably large. (5) We did not relate our results 
to body height or age. This factor may hold some relevance for latencies of motor 
evoked potentials, but not for areas of motor evoked potentials and central motor 
conduction times. The central motor conduction times in particular is unrelated to 
age and body height after the age of five years [29,30].
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In conclusion, the contribution of upper motor neuron dysfunction to lower limb 
motor impairment is more considerable than expected from neurologic examina-
tion of children with spina bifida. This upper motor neuron dysfunction seems to 
originate in the corticospinal tract above the spinal anomaly. These findings pro-
vide additional understanding of the complex corticospinal and spinal pathology of 
spina bifida. As such, transcranial magnetic stimulation may be of value in clinical 
settings and in research settings, for the objective assessment motor impairments 
in spina bifida.
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Spinal dysraphism is a severe congenital malformation of the central nervous sys-
tem with a highly variable and unpredictable outcome. Because of the complexity 
of spinal dysraphism and its heterogeneity in presentation and outcome, a lot of 
research has been done worldwide concerning prevention, early prenatal detec-
tion and optimization of perinatal and postnatal care for patients with a neural 
tube defect and their families. Among all of these efforts, the most recent, most 
impressive and perhaps most promising approach to early intervention is foetal, 
thus ‘in utero’, surgery [1]. Irrespective of all diagnostic and therapeutic advances, 
it is still extremely difficult - if not impossible - to predict the neurological outcome 
(including, but not limited to cognitive, behavioural, and motor development) 
of an individual foetus or neonate with a neural tube defect. Clinically relevant, 
robust, non-invasive and objective measures are needed for reliable prediction of 
an individual long-term prognosis to optimize prenatal counselling, including deci-
sions on termination of pregnancy and foetal therapy, and appropriate follow-up 
of new-borns with spina bifida (whether or not operated during foetal life).
The aim of this thesis was to study infants with a neural tube defect prenatally and 
postnatally to determine whether available diagnostic techniques would lead to 
better insights into the prognosis of their neurodevelopmental outcome. Specifi-
cally, we searched for prognostic markers for neurodevelopmental outcome based 
on findings in clinical examination, ultrasound imaging and neurophysiological 
investigations, such as percutaneous electrical stimulation and motor evoked 
potentials as well as electroencephalography. After some methodological consid-
erations, the results of the studies described in Chapters 2 through 6 are put into 
perspective in light of the aim of the thesis and the existing literature on spinal 
dysraphism. Finally, the future perspectives for research and treatment of spinal 
dysraphism are discussed.
Methodological Considerations
Study Design
The study concerning biparietal diameter and head circumference (Chapter 2) and 
the study on birth mode (Chapter 3) described in this thesis were based on retro-
spectively collected data. Compared to prospective, randomized controlled trials, 
our studies provide lesser amounts of evidence for causal interference. However, 
the strengths of the first study are that it concerns a complete, unselected cohort 
of prenatally detected foetuses with spinal dysraphism and pertains to the highly 
reproducible BPD as a routine 2nd trimester scan measurement. The retrospective 
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nature of the study in Chapter 3 was our only option, as few infants with spinal 
dysraphism are born in the Netherlands nowadays. So a randomized controlled 
trial with adequate study power is unlikely ever to be performed here or in most 
other European countries anymore. Therefore, a retrospective unselected cohort 
was used to answer the question upcoming parents have to face concerning the 
optimal route of delivery for their infant with spinal dysraphism.  
The neurophysiological studies in this thesis (Chapters 4, 5, and 6) were based on 
prospective data for which data collection started in January 2002. A cohort of 44 
new-born infants with spinal dysraphism was included prospectively and followed 
into early childhood. In addition, a cohort of 56 school-age children with spinal 
dysraphism was recruited from the outpatient clinics. The strength of these stud-
ies is the participation of neonates as well as school-age children. During the study 
period, all neonates born in or referred to our centre were included and were all 
systematically investigated by two trained paediatric neurologists before surgical 
closure of the spinal anomaly. Generally accepted and well-established neurophysi-
ological methods and clinical impairment measures were used. These studies also 
had some limitations, however. The sample sizes of the cohorts were smaller than 
anticipated at the start of the study period. The most important reason for the 
small neonatal cohort was the decreasing prevalence of live born children with spi-
nal dysraphism in the Netherlands due to the introduction of the mid-pregnancy 
screening program in 2007 and subsequent higher numbers of termination of 
pregnancy [2]. In addition, some children were lost to follow-up due to migration 
or withdrawal of consent. In the cohort of school-age children, the willingness 
to participate was lower than expected because of the burden that the research 
protocol placed upon children and parents, so non-response bias cannot be ruled 
out. Despite the small sample sizes, the results provided new pathophysiological 
insights into some neurophysiological aspects of neural tube defects. 
Measurements
Other methodological considerations concern Transcranial Magnetic Stimulation 
(TMS). TMS can result in direct corticospinal tract excitation or in indirect corti-
cospinal tract excitation by trans-synaptic excitation of cortical interneurons [3]. 
In healthy subjects, high TMS intensities mainly lead to direct excitation, while low 
TMS intensities lead to indirect excitation [4]. In children with spinal dysraphism, 
the proportions of direct and indirect excitation relative to TMS intensity are 
unknown. Determination of motor thresholds or stimulus-response curves might 
have provided more information about cortical excitability [5]. We performed TMS 
at 100% intensity and did not use a predefined percentage above threshold, so the 
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degree of intensity above threshold may have differed between control children 
and children with spinal dysraphism. 
Spinal magnetic stimulation results in activation of motor nerve roots at the 
site where they leave the intervertebral foramen. At this site, the magnetic field 
focuses and the stimulus threshold is low. As the spine insulates the spinal cord, 
direct stimulation of the spinal cord is impossible [6,7]. Obviously, in children with 
spinal dysraphism, the exact site of activation might be difficult to predict, due to 
abnormal spinal anatomy at the neurological (spinal cord) as well as bony (spine) 
level. Theoretically, excitation could also occur at corticospinal level. The unaf-
fected peripheral latencies in children with spinal dysraphism compared to control 
children (Chapter 6), however, do not support this hypothesis. The absence of 
bony insulation and the more superficial localisation of neural tissue may also 
result in the activation of relatively more axons. The lumbosacral MEP areas in our 
study support this assumption, as the MEP areas in the gastrocnemius and tibi-
alis anterior muscles seem to approach the supramaximal CMAP areas generated 
in the same muscles in children without spinal dysraphism. This may explain the 
more obvious differences between children with spina bifida and control children 
for the CMAP areas than for the lumbosacral MEP areas. 
The CMCTs were calculated from the differences between the latencies of the 
transcranial and the lumbosacral MEPs. Considering the fact that lumbosacral 
magnetic stimulation results in activation of motor nerve roots at the site where 
they leave the intervertebral foramen, the calculated CMCT includes part of the 
proximal spinal motor neuron. The contribution of the proximal part is relatively 
small, however, and equal in children with spina bifida and control children, be-
cause the lumbosacral MEP latencies did not differ between these children. Other 
methods to measure the CMCT are available. Using the F-response latency for 
instance, the CMCT might be more precise [3]. However, F-responses are highly 
variable in latency, may be difficult to obtain in affected nerves, and are difficult to 
interpret in multisegmentally innervated muscles. Moreover, performing 10 to 20 
reliable electrical stimuli may be a large burden for children. Using a triple stimula-
tion technique, the corticospinal motor conduction time can be measured more 
precisely [8]. However, this method is only suitable for the upper and a few lower 
limb muscles and can be very painful [9]. 
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Main findings and clinical implications in light of the current context
Prenatal Life and Foetal Surgery
Counselling and ultrasound imaging in relation to prognosis
Despite the overall decreasing birth prevalence of neural tube defects, counsel-
ling expectant couples carrying foetuses with neural tube defects still constitutes 
an increasing proportion of the clinical practice of paediatric neurologists since 
the introduction of the screening program in The Netherlands. The decision to 
terminate a pregnancy or carry it to term and provide care for a child with a neural 
tube defect is complex and very private. Prenatal surgery is a relatively hot topic in 
the field of neural tube defects and the consideration of prenatal surgery needs to 
be included in the decision process. The now available high-resolution ultrasound 
with state-of-the-art equipment allows us to make a very accurate diagnosis of 
open spinal dysraphism, providing detailed information on the anatomy of the en-
tire foetal central nervous system. Foetal magnetic resonance imaging (MRI) may 
be added as a diagnostic imaging strategy, and prenatal genetic testing is available 
for screening for underlying chromosomal abnormalities. Despite all technical ad-
vances, the prognostic values of the morphological (sonographic or MRI) features 
in relation to neurodevelopmental outcome are still largely unknown. In studies 
of intrauterine repair of neural tube defects, the upper level of the lesion was the 
strongest predictor of shunt requirement, while the mean lateral ventricular size 
measured just before intrauterine repair was another reliable measure predicting 
shunt requirement [11]. The anatomical level of the spinal cord lesion, however, 
may not correspond to the clinical level of neurological (dys)functioning, and 
ultrasound was not found to be predictive for postnatal mobility or intellectual 
function [10]. Taking into account the complexity and the consequences of the 
process of prenatal decision making, more accurate prenatal predictors of neuro-
developmental outcome in patients with neural tube defects are needed. 
We decided to investigate other prenatal anatomical ultrasound markers and 
their potential association with neurodevelopmental outcome. In the literature, 
biparietal diameter (BPD) and head circumference (HC) were not mentioned 
as a prognostic marker for neurodevelopmental outcome in children with open 
spinal dysraphism. In our cohort, we found a small biparietal diameter and head 
circumference in foetuses with spinal dysraphism (Chapter 2). Of all cases with 
open spinal dysraphism, 62.2% had a BPD < 3rd centile and 79.7% had a BPD < 10th 
centile. Among all foetuses, 54.1% had a HC < 3rd centile and 74.3% had a HC < 
10th centile. Small BPD and HC values represent the loss of extra-axial fluid volume 
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between foetal brain and skull as a consequence of fourth ventricle obstruction 
associated with Chiari II malformation, which prevents CSF from draining through 
the fourth ventricle to maintain the extra-axial fluid space. A small BPD and HC in 
case of normal or increased extra-axial fluid spaces may suggest a morphologically 
smaller brain with an increased risk of poor cognitive outcome. In our population, 
lateral ventricular width was normal in 34 fetuses (46%). Mild ventriculomegaly 
was seen in 33 foetuses (45%) and severe ventriculomegaly in 6 foetuses (8%). 
Of the 6 foetuses with severe ventriculomegaly, 3 fetuses had a small HC and BPD 
(2 at the 3rd percentile and 1 lower than the 3rd centile). In spinal dysraphism, 
however, hydrocephalus and Chiari malformation do not occur independently 
and severe ventriculomegaly is also seen in fetuses with a small BPD. Because of 
their interrelatedness, it remains a challenge to disentangle hydrocephalus, Chiari 
malformation, and small BPD and HC [12]. The association between small BPD 
and HC and cognitive outcome in foetuses with normal brain volume and reduced 
extra-axial fluid spaces is still poorly understood. Cognitive impairment in children 
with spinal dysraphism is highly variable and has frequently been attributed to the 
severity of the hydrocephalus and associated complications, such as shunt revi-
sions, infections, or seizures [13]. Because we measured a complete, unselected 
cohort of prenatally detected foetuses with neural tube defects, we expected to 
see the same known variation in neurodevelopmental outcome in our population 
as well, although we could not verify this due to the large number of terminated 
pregnancies. Still, we conclude that the small BPD and HC in fetuses with open spi-
nal dysraphism should be considered part of its phenotype and not an independent 
prognostic marker for poor cognitive outcome. 
Many young couples pregnant of a foetus with a neural tube defect focus on chances 
of ambulation, while quality of life (QoL) for patients themselves is based on living 
independently, finding a partner and a paid job, and urinary and faecal continence 
as well as sexual functions. Knowledge of the quality of life of persons with a neural 
tube defect is relevant with regard to today’s policies of termination of pregnancy 
early in gestation, the use of new surgical techniques, such as prenatal surgery, 
and deciding whether or not to treat early after birth. Barf et al [14] studied life 
satisfaction and its determinants for young adult with spinal dysraphism and used 
The Dutch Life Satisfaction Questionnaire, which includes one question about 
life satisfaction as a whole and eight domain-specific single items. The number of 
young Dutch adults with a neural tube defect (age range 16–25 years) dissatisfied 
with life was low (24%), and overall life satisfaction was not different from the 
reference group. However, significant differences were found in self-care ability, 
financial situation, partner relationships, and sex life, with the spina bifida group 
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reporting less satisfaction in these domains. Murray et al [15] published their 
study on Health-Related Quality of Life (HRQoL) in children and adolescents with 
spina bifida in 2015. HRQoL is a multi-domain concept that represents a patient’s 
overall perception of the impact of an illness and its treatment. HRQoL captures 
physical, psychological (including cognitive and emotional), and social functioning 
issues. In this study, parents reported significantly lower social and physical HRQoL 
compared with HRQoL reported by the patients. It is possible that the child with a 
neural tube defect adapts to his or her physical and social limitations, while parents 
continue to compare their child’s quality of life with that of typically developing 
siblings or peers. Due to the neurocognitive impairments associated with spinal 
dysraphisms, discrepancies between parent and youth reports may also reflect 
impairments in higher-level metacognitive abilities needed for self-assessment. 
Parents really need an estimation of likely degree of disability and the prognosis 
for an independent life as an adult for their child. Verhoef et al [16] concluded 
that patients with hydrocephalus and a lesion at L2 or above were dependent 
regarding sphincter control (98%), locomotion (79%), and self-care (54%), and 
quite a few needed support in transfers (38%), social cognition (29%), and com-
munication (15%). Their study was performed in young adults with a neural tube 
defect and the level of the lesion was defined as the lowest completely unimpaired 
dermatome level on both sides measured with sensitivity to pin prick and light 
touch. Nowadays, three-dimensional ultrasounds are used, which will most likely 
be more accurate for localisation of lesion level in the prenatal phase. However, 
outcome is still predicted based on the prenatal bony lesion and -logically- not 
the neurological motor or sensory levels, whereas the sensory level seems more 
accurate in predicting outcome after birth. 
Prognosis of level of functional independence might support decisions concerning 
termination of pregnancy, prenatal surgery, and postnatal treatment of children 
with a neural tube defect. Empirically based knowledge of prenatal prognostic 
markers for functional independence are crucial in counselling parents and pa-
tients with a neural tube defect. The focus for prenatal counselling and outcome 
measures in studies on foetal surgery should ideally be on final independency in 
adult daily activities, chances for a paid job, partner relationships and sex life, and 
not (only) on anatomical level of the spinal defect or requirement of a shunt for 
hydrocephalus. 
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Birth Mode
The optimal delivery route in infants with a prenatal diagnosis of spinal dysraphism 
has been a matter of debate. In the absence of randomized controlled trials, evi-
dence relies on case series. On the one hand, one argued in favour of caesarean 
delivery, theorizing that increased pressure on exposed neural tissue during vagi-
nal delivery would result in additional loss of neural function, especially in cases of 
breech delivery [17]. On the other hand, one argued in favour of vaginal delivery 
primarily because of lack of evidence that caesarean section is of beneﬁt, despite 
the recognized neonatal and maternal risks [18]. Women who choose to continue 
their pregnancy still face the question how to deliver in their infants’ best interest. 
Especially now fewer infants with spinal dysraphism are being born, it is unlikely 
that randomized controlled trials will ever be performed. In view of the conflicting 
policies, we decided to perform a retrospective review study of route of delivery 
for babies born with a neural tube defect (Chapter 3). In our retrospective cohort 
study of 95 infants with a myelomeningocele, the functional and anatomical defect 
levels were measured and the difference between functional and anatomical levels 
was determined (ΔFAX) as effect measure of birth mode. We concluded that there 
is no evidence that caesarean section has a beneficial effect on neurological out-
come in infants with myelomeningocele. Caesarean section should be performed 
on obstetric indication only. Recently, Green et al [19] published a comparable 
study on this subject, in which they used functional level defined as the lowest level 
of purposeful movement on either side of the body at 24 months of age instead of 
during the first days after birth. They found no benefit of caesarean delivery and 
no effect of labour on neurological outcome either.  
Postnatal life
Although the overall outcome of children with spinal dysraphism has improved 
over the past decades, reliable prediction of an individual long-term prognosis for 
a neonate born with a neural tube defect is still difficult [20,21]. Several studies 
concerning survival and outcome of patients with spinal dysraphism are available 
in the literature. As a result of modern neurosurgical intervention procedures, such 
as closing the defect and inserting a cerebrospinal fluid (CSF) shunt for hydro-
cephalus when required [22], and high standard urological care, the mortality rate 
substantially declined over the past decades and spina bifida is now compatible 
with long-term survival. 
In addition to the range of medical and physical consequences, spinal dysraphism 
may also have an impact on cognitive development. In general, children with a 
neural tube defect tend to have intelligence scores within the low-average to 
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average range. The intelligence distribution is shifted towards the lower end of 
the spectrum by approximately one standard deviation [23, 24, 25]. Cognitive 
outcome is associated with numerous factors among which the severity and loca-
tion of the spinal defect: the higher the lesion, the poorer the cognitive outcome. 
Furthermore, the presence of hydrocephalus is associated with poorer outcome, 
with the annotation that cognitive impairments are related to the number of shunt-
related complications in particular [26,27]. Other studies suggest that cognitive 
outcome is associated with impact of the hydrocephalus on cerebral white matter 
[28, 29]. Children with a neural tube defect show a distinctive cognitive pheno-
type, expressed both as variations across content domains, e.g. higher Verbal IQ 
than Performance IQ and better reading than mathematics, and variations within 
content domains, e.g. better grammar and vocabulary skills, but poor pragmatic 
language. It involves naturally occurring systematic variability in the genotype, 
neural phenotype and environment, which is related to individual differences in 
the cognitive phenotype [30,31]. 
An important aim of our studies was to obtain insight into the variability of neuro-
cognitive deficits in children with spinal dysraphism in general, and in relation to 
the associated cerebral comorbidity. We searched for robust prognostic markers 
for cognitive impairment. It is generally accepted that neonatal electroencepha-
lography (EEG) is a powerful tool to assess the prognosis of cognitive impairment 
in (preterm and) term infants. Markedly abnormal background patterns are as-
sociated with poor neurological outcome, while normal background patterns are 
associated with good neurological outcome [32, 33, 34]. Since neural tube defects 
are associated with cerebral dysgenesis, we hypothesised that EEG recordings 
might differentiate between those with and without serious cerebral comorbidity 
(Chapter 4). In our study, however, all infantile EEGs were normal despite known 
cerebral malformations. Four (13%) patients developed epilepsy at an average age 
of 35 months (range 27-48 months). Two of these four patients had a severely 
delayed development (MDI<55). So, the prognostic value of a single neonatal EEG 
seems to be very limited in neonates with spina bifida. 
Infants born with a neural tube defect are investigated during the first 24 hours 
after birth and sensory, motor, cutaneous, and radiological levels of the lesion are 
assessed in detail before surgical closure of the defect. Clinical determination of 
motor impairment in new-born infants with a neural tube defect is complex. Motor 
impairment level is assessed on each side separately and scored according to the 
lowest intact spinal segment with lasting non-stereotypical, non-reflex lower limb 
movements. Sensory impairment is assessed on each side of the body separately 
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and scored according to the lowest intact dermatome, defined as the presence of 
behavioural reactions to pin prick or light touch in this dermatome. The demarca-
tion of impairment to spinal segments is a simplification of the actual impairment, 
because residual motor and sensory function is present in affected spinal segments 
caudally from this demarcation. Spinal dysraphism has a complex neuropathology 
involving corticospinal and spinal motor pathways. Consequently, motor impair-
ment in lower limbs may result from lower motor neuron (LMN) and upper motor 
neuron (UMN) dysfunction. The neurophysiological studies in the thesis of Niels 
Geerdink (http://repository.ubn.ru.nl/bitstream/handle/2066/102353/102353.
pdf?sequence=1) and in this thesis provided some new insights in the proportional 
LMN and UMN dysfunction in relation to the multilevel pathology of spinal dysra-
phism. Lower motor neurons are alpha-motor neurons (e.g. anterior horn cells) 
located in the ventral horns of the spinal cord with axons leaving the spinal cord 
through the ventral roots to innervate voluntary muscles. Upper motor neurons 
are motor neurons with their cell bodies in the cerebral cortex and their axons 
descending into the spinal cord to make synaptic connections with spinal alpha-
motor neurons in the ventral horns. During embryonic development of the spinal 
cord, the axons of the corticospinal tract descend into the spinal cord to make 
these synaptic connections with spinal motor neurons [35,36], originating in the 
ventral section of the neural tube. The descend of corticospinal tract axons in the 
lateral sections of the spinal cord may be disturbed to a larger extent than the 
development of anterior horn cells in the relatively sheltered ventral section. In 
addition, functional synaptic corticospinal connections to spinal motor neurons 
are established during the final trimester of gestation in normal development [35]. 
In neural tube defects, the ‘second hit’ (see introduction and below) to the vulner-
able neuroplacode may harm proper establishment of these synaptic connections. 
Spinal ischemia resulting from aberrant spinal cord blood vessels in combination 
with reduced blood flow during delivery may further harm these connections [37]. 
Magnetic stimulation is a non-invasive method to evaluate motor pathways with 
proven diagnostic value in several disorders, such as myelopathy, stroke and amyo-
trophic lateral sclerosis, while prognostic value is reported for multiple sclerosis 
and stroke as well [3,4,5,38]. In children, magnetic stimulation provided additional 
understanding of the development and maturation of the central nervous system 
and its plasticity following early brain injury [39]. We tried to disentangle UMN 
involvement from LMN involvement by using transcranial and lumbosacral MEPs 
and CMAPs. We suggested that MEPs and CMAPs might be useful tools to assess 
residual function in children born with spinal dysraphism. In Chapter 5, we de-
scribed that MEPs and CMAPs of the gastrocnemius and tibialis anterior muscles 
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seem to be of prognostic value for motor development towards ambulation at 
two years of age. The clinical phenotype of a child with a neural tube defect is 
generally dominated by flaccid paresis of the lower limbs, so presence of UMN 
dysfunction might be underestimated. Spasticity is seen in less than 50%, whereas 
our results showed UMN dysfunction in almost all children [40,41,42]. The contri-
bution of UMN dysfunction to lower limb motor impairment is more considerable 
than expected from neurological examination alone. The UMN dysfunction seems 
to originate in the corticospinal tract above the spinal anomaly and is related to 
functional outcome. The ability to walk was associated with the degree of UMN 
dysfunction in our study. TMS may have a diagnostic value in revealing clinically 
hidden UMN dysfunction and can be helpful to detect deterioration of UMN func-
tion. Secondary tethering of the spinal cord is commonly seen in growing children 
with spinal dysraphism, and this complication is associated with UMN dysfunction. 
TMS may help us to detect early symptomatic tethered spinal cord, and MEPs and 
CMAPs may be valuable in complex cases where there is doubt about the func-
tional level of the lesion. 
So MEPs and CMAPs can be used as additional tools for prognosis, but clinical 
neurological examination still remains the preferred method. 
In Chapter 6, we reported our investigation of LMN and UMN in school-age chil-
dren with a neural tube defect.  In this study, reproducible transcranial MEPs were 
obtained after TMS and UMN dysfunction was demonstrated by reduced transcra-
nial MEP areas and prolonged central motor conduction times (CMCTs) in children 
with spinal dysraphism compared to control children without a neural tube defect. 
CMAPs and lumbosacral MEPS provided information about LMN function. CMAP 
areas were smaller in children with a neural tube defect than in control children. 
The MEP and CMAP areas seem to reflect the severity of neurological impair-
ment, as severely affected new-born infants and school-age children had smaller 
MEP and CMAP areas than mildly affected patients. The latencies of CMAPs and 
lumbosacral MEPs provide additional information about LMN function. Overall, 
peripheral latencies did not differ essentially from peripheral latencies in control 
children without a neural tube defect, but among children with spinal dysraphism, 
CMAP latencies were longest in severely impaired children. These findings show 
that both UMN and LMN dysfunction are involved in motor impairment in the 
lower limbs. Clearly prolonged CMCTs in contrast to relatively spared peripheral 
motor latencies may point out that UMN dysfunction is the primary factor in mo-
tor impairment. 
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Recently, Oakeshott et al published their long-term outcome data after a 50-year 
complete community-based prospective cohort study for treated neural tube de-
fects (n=117). In this cohort, those with the best results were born with a sensory 
level below L3. They were more likely to survive to adulthood, to walk, be conti-
nent of urine, to have normal intelligence (IQ ≥80), and to live independently in 
the community. The authors concluded that sensory level predicts outcome better 
than cutaneous or radiological level and should be assessed in all children born 
with a neural tube defect [43, 44, 45, 46 ,47]. 
Future perspectives – Foetal therapy: why, who, and where?
Prenatal counselling has become more complex because of foetal surgery options. 
The Management of Myelomeningocele Study (MOMS trial) shows that open 
foetal surgery may improve neurological outcome. Given the novelty of the tech-
nique, however, long term follow-up data are still unavailable, and the underlying 
mechanisms that might lead to improved outcome are in fact unknown. Delayed 
spinal cord damage, superimposed on the congenital malformation of the neu-
ral tube itself, is referred to as the “second hit”. The putative pathophysiologic 
mechanism of this “second hit” involves mechanical as well as neurotoxic damage 
because of absence of neural coverage. 
In contrast to the potential benefits for the foetus with a neural tube defect, 
prenatal open surgery is also associated with maternal and foetal risks, such as 
preterm birth, intraoperative complications and uterine scar defects. Further 
improvement of the pre-operative estimation of the individual benefits (thus: the 
prognosis for the foetus, with and without surgery) and risks (for the mother as 
well as the foetus), and further improvement of surgical techniques, are important 
issues. Recently, the results of a phase 1 trial of endoscopic surgery instead of 
open surgery for the antenatal treatment of spinal dysraphism were published and 
showed minimal maternal morbidity, but further phase II trials need to be done 
now [48,49, 50, 51]. In addition, outcome should be assessed in larger groups of 
patients over a longer period of time before considering implementation of foetal 
myelomeningocele closure as standard -as opposed to experimental- care. Right 
now, intrauterine surgery in accordance with the MOMS trial is offered in Leuven, 
Belgium, to patients from all over Europe. 
Neurophysiological investigation may provide additional understanding regarding 
the mechanisms that lead to improved motor outcome after prenatal surgery. So it 
might be interesting to use MEPs and CMAPs in those children, not only to evalu-
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ate the outcome of prenatal surgery, but also to obtain insights into the underlying 
mechanisms.
Future perspectives – The study of pathophysiology and prognosis
The use of foetal MRI has become an important adjuvant tool for perinatologists 
and paediatric neurologists to aid in counselling parents of foetuses diagnosed 
with spinal dysraphism on ultrasound. Mangels et al  [52] demonstrated the ability 
to accurately characterise the level of the myelomeningocele within one or two 
vertebral levels in 89% of cases using MRI. MRI seems to be equally accurate to 
ultrasound imaging for prediction of the highest affected bony level. It is generally 
accepted, however, that the cerebral anatomy can better be visualized with foetal 
MRI than ultrasound. Thus, MRI might be the preferred technique to estimate the 
impact of cerebral comorbidity on the prognosis. It is, however, important to real-
ize that the consequence of a certain marker (or abnormality) may differ between 
an otherwise healthy foetus and a foetus with spinal dysraphism. We showed that 
for head size in Chapter 2: in the general population, (foetal) microcephaly is 
considered a marker or risk factor for poor cognitive outcome, while microcephaly 
is part of the “normal phenotype” of many foetuses with spina bifida at 20 weeks 
of gestation.
Advanced MR Imaging might offer new insights in the pathophysiology of neural 
tube defects and may be of prognostic value. Diffusion Tension Imaging (DTI) is 
an advanced medical imaging technique allowing investigation of the orientation 
and location of nerve fibres. White matter bundles and abnormal grey matter can 
be visualised by using DTI and volumetric MRI studies. Functional MRI (fMRI) 
detects local hemodynamic changes following increased metabolic rate in neural 
activity. An outstanding advantage of fMRI is the opportunity to measure actual 
task performance of a patient simultaneously with functional imaging. Applying 
these and other novel techniques may contribute enormously to getting closer 
in understanding the pathophysiology and functional problems in children with 
neural tube defects. 
Future perspectives – The organisation of care
Neural tube defects are becoming orphan diseases in most countries since the 
improvement of preventive measures and the possibilities for termination of the 
majority of remaining affected pregnancies. At the same time, prenatal counsel-
ling has become more complex because of a lack of reliable prognostic factors 
and complex choices regarding termination of pregnancy on the one hand, and 
foetal surgery options on the other hand. Prenatal care in general needs an expert 
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team of obstetricians, gynaecologists, neonatologists and paediatric neurologists 
for couples pregnant of a baby with a neural tube defect. Foetal surgery needs 
centralization of care for the purpose of obtaining experience in this specific 
type of surgery. Perinatal care for infants born with a neural tube defect requires 
experience as well. Multidisciplinary teams improve the diagnostic process, care, 
and treatment for these children. The multidisciplinary team ideally consists of a 
paediatrician, an orthopaedic surgeon, a rehabilitation physician, a urologist (and 
sexologist), a neurosurgeon, a physiotherapist, a social worker, a specialised nurse, 
and a paediatric neurologist. In the Netherlands, these teams are operational in all 
university medical centres, but they are vanishing because of the decreased num-
ber of children born with a neural tube defect. Therefore, prenatal and postnatal 
care for these children requires centralisation. Transition of care to adult medicine 
is another matter of concern, and in most centres, transition should be further 
optimised. Patients are complaining about too little expertise in adult medicine 
concerning the problems they are facing once they are becoming grown-ups. 
Future perspectives – Research and Prevention
The ultimate future goal would be primary prevention of neural tube defects to 
avoid the complex and often heart-breaking decisions surrounding secondary and 
tertiary prevention. Therefore, further unravelling of the specific pathophysiologic 
processes that cause neural tube defects is needed. Future genetic research using 
e.g. whole exome or whole genome sequencing and studies on environmental in-
fluences and gene-environment interactions are warranted to further elucidate the 
multifactorial aetiology of spinal dysraphism. Importantly, the future prevalence of 
spinal dysraphism could already be decreased in many regions of the world (in-
cluding Europe and The Netherlands) now, simply by intensifying the prevention 
programs and maybe also by following the example of mandatory fortification of 
flour with folic acid that has proven to be effective in other parts of the world [53].
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Summary
Chapter 1 provides the general introduction to this thesis, starting with basic 
information about the prevalence, features and definition of spinal dysraphism, 
followed by preventive measures and their consequences. Spinal dysraphism can 
be detected prenatally by an ultrasound scan, which may lead to termination of 
the pregnancy. Counselling of the prospective parents on this decision, however, 
is extremely difficult as no reliable individual prognosis for the child with spinal 
dysraphism can be given in the majority of cases. Nowadays, the option of foetal 
surgery of the defect may also be considered, but postnatal prediction of long-
term outcome remains a big challence. The chapter concludes with the aim and 
outline of this thesis.
Chapter 2 describes a retrospective study to assess foetal biparietal diameter 
(BPD) and head circumference (HC) in the second trimester of pregnancy in 
foetuses with open spinal dysraphism as possible prognostic markers for cognitive 
outcome. BPD and HC were measured at 16-26 weeks in 74 foetuses with open 
spinal dysraphism and compared to reference values. Of all cases with open spinal 
dysraphism, 62.2% had a BPD < 3rd centile and 79.7% had a BPD < 10th centile. 
Of all patients, 54.1% had a HC < 3rd centile and 74.3% had a HC < 10th centile. 
Almost all foetuses with open neural tube defects have a smaller BPD and HC at 
16-26 weeks compared with reference values, which implicates that these are part 
of the phenotype of children with open spinal dysraphism instead of independent 
prognostic markers for a poor cognitive outcome.  
Chapter 3 provides the description of a retrospective cohort study, including 95 
neonates with myelomeningoceles born between 1990 and 2006, to assess the 
effect of delivery mode on early neurologic outcome. This effect was assessed 
as the difference between functional neurological level and X-ray level (ΔFAX). 
Early neurological outcome was better in the vaginally delivered infants than in 
those delivered by cesarean section. Multivariable linear regression analysis with 
correction for confounding demonstrated that vaginal delivery was associated 
with better early neurological outcome as compared to cesarean section (β=1.21; 
95% CI 0.16; 2.27; P=0.03) for infants in vertex and breech position combined. 
Subgroup analysis revealed a non-significant trend towards better outcome after 
vaginal delivery, which was more pronounced in infants in breech position than in 
vertex position. In infants with myelomeningocele, born in either vertex or breech 
position, there is no clinical evidence that early neurological outcome is improved 
by cesarean section.
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In Chapter 4, a prospective study on the prognostic value of a single early infantile 
electroencephalography (EEG) is described for infants born with spina bifida. 
Thirty-one infants born between 2002 and 2007 were evaluated and followed up 
for 2 and a half years to assess their cognitive development and physical disabilities. 
All EEG recordings were within normal limits, but 3 out of the 31 children showed a 
mild mental disability and major physical disabilities. We concluded that single EEG 
recordings are of limited prognostic value for infants born with spina bifida. Serial 
EEG recordings in combination with other neurophysiologic investigations, such as 
MEPs and CMAPs, might show better prognostic value. 
In the study described in Chapter 5, lumbar motor evoked potentials (MEPs) and 
compound muscle action potentials (CMAPs) were assessed to determine their 
prognostic value in comparison to clinical neurologic examination in infants with 
spina bifida. Thirty-six neonates born between 2002 and 2007 were evaluated and 
followed for 2 years. MEPs were recorded from the quadriceps femoris, tibialis an-
terior, and gastrocnemius muscles and CMAPs from the latter two muscles before 
surgical closure of the spinal anomaly. Better clinical neurologic outcome at the 
age of 2 years, defined by better Muscle Function Classes and ambulation status, 
was associated with larger MEP and CMAP areas of the gastrocnemius and tibialis 
anterior muscles at neonatal age. In spina bifida, MEPs and CMAPS of these two 
muscles are of prognostic value for clinical neurological outcome and might be 
useful to assess residual motor function. 
Chapter 6 reviews the progress made in understanding the pathogenesis of spina 
bifida. We aimed to disentangle the proportional contribution of upper and lower 
motor neuron dysfunction to motor impairment in children with spina bifida. We 
enrolled 42 school-aged children with spina bifida and 36 control children of similar 
age. Motor impairment was graded to severity scales in children with spina bifida. 
We recorded MEPs after transcranial and lumbosacral magnetic stimulation and 
CMAPs after electric nerve stimulation. Regarding lower motor neuron function, 
severely impaired children with spina bifida demonstrated smaller CMAP areas 
and lumbosacral MEP areas than control children; mildly impaired children hardly 
differed from control children. CMAP and MEP latencies did not differ between 
children with spina bifida and control children. Regarding upper motor neuron 
function, children with spina bifida demonstrated smaller transcranial MEP areas 
and longer central motor conduction times than control children. The smallest 
MEP areas and longest central motor conduction times were observed in severely 
impaired children. We concluded that the contribution of upper motor neuron 
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dysfunction to motor impairment in children with spina bifida is more considerable 
than expected from clinical neurologic examination. 
Chapter 7 contains the general discussion, in which we put the results of the 
studies described in the previous chapters into perspective in light of the aim of 
this thesis and the current context, after addressing a number of methodological 
considerations pertaining to study designs and measurements used. The complex 
process of counselling and decision making surrounding prenatal detection of 
spinal dysraphism, may be aided by advanced diagnostic techniques, but it is still 
impossible to provide an adequate individual prognosis for the majority of cases, 
especially taking into account the differences in valuation of quality of life between 
prospective parents and patients. Prenatally assessed biparietal diameter and head 
circumference do not contribute to the prognosis and neither does mode of deliv-
ery. Foetal surgery, however, may greatly increase the prognosis of children with 
spinal dysraphism, despite the risks for mother and child involved in the procedure. 
Advanced imaging techniques may be used to evaluate the impact of foetal surgey 
and learn more about the pathophysiologic processes involved in spinal dysrahism. 
In addition, future perspectives should include aetiologic studies, primary preven-
tion, and centralized care of children with spinal dysraphism.     
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Samenvatting
Hoofdstuk 1, de inleiding van dit proefschrift, beschrijft achtergrondinformatie 
over spina bifida, zoals de prevalentie en de omschrijving van verschillende typen 
spinaal dysrafismen.  Een neuraalbuisdefect kan prenataal met de zogenaamde 
strukturele “20 weken” echo worden vastgesteld, daarna vindt counselling plaats 
van de toekomstige ouders. Deze counselling, meestal uitgevoerd door obstetri-
cus en kinderneuroloog, is echter complex gezien het feit dat een betrouwbare 
individuele prognose in de meerderheid van de gevallen bij het vaststellen van een 
neuraalbuisdefect lastig te geven is op basis van de gegevens bij prenatale echo. 
Het anatomische niveau van het defect en de schedelomvang zijn van voorspel-
lende waarde voor overleving, echter het anatomisch niveau kan 1 a 2 niveaus ver-
schillen van het funktionele niveau en goede prenatale echomarkers voor kwaliteit 
van leven zijn er niet. Ouders krijgen, na het vastellen van een neuraalbuisdefect 
bij hun ongeboren kind, een drietal opties, (1) afbreken van de zwangerschap 
voor de 24ste week amenorroeduur, (2) prenatale intrauteriene chirurgie of (3) 
de zwangerschap uitdragen. De doelstelling van het onderzoek - beschreven in 
dit proefschrift- is, om kinderen met neuraalbuisdefecten pre- en postnataal te 
onderzoeken en met huidige diagnostische technieken te kijken of er betere prog-
nostische markers voor toekomstig funktioneren en neurocognitieve ontwikkeling 
te vinden zijn.
In hoofdstuk 2 wordt een retrospectieve studie beschreven, waarin prenataal de 
bipariëtale diameter (BPD) en schedelomvang werden gemeten in het tweede 
trimester van de zwangerschap bij foetussen met een open spinaal dysrafisme, als 
mogelijk prognostisch markers voor cognitieve outcome. BPD en schedelomvang 
werden gemeten bij 16-26 weken amenorroeduur bij 74 ongeboren kinderen 
met spina bifida en vergeleken met de referentiewaarden. Van alle kinderen met 
een open neuraalbuisdefect, heeft 62.2% een BPD kleiner dan het 3e percentiel 
en 79.7% heeft een BPD onder het 10e percentiel. Van alle kinderen had 54.1% 
een schedelomvang kleiner dan het 3e percentiel en 74.3% had een hoofdomtrek 
kleiner dan het 10e percentiel. Concluderend hebben dus bijna alle foetussen met 
een open neuraal buisdefect een kleiner BPD en hoofdomvang dan de referentie-
waarden, hetgeen impliceert dat dit onderdeel is van het fenotype van foetussen 
met een neuraalbuisdefect in plaats van een onafhankelijke prognostische marker 
voor het  neurocognitieve funktioneren.
In hoofdstuk 3 wordt de retrospectieve cohort studie beschreven, waarin 95 neo-
naten met een myelomeningocele geboren tussen 1990 en 2006, beschreven wer-
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den, waarbij gekeken werd naar het effect van partusmodus op vroeg neurologisch 
funktioneren postpartum. Dit effect werd vastgesteld door het verschil tussen het 
funtioneel neurologisch niveau en röntgen niveau (laagst intacte wervelboog) te 
berekenen. Het funktioneel niveau na de geboorte bleek iets beter in de groep 
kinderen die per vaginale partus werd geboren in vergelijking met de groep kin-
deren die per sectio caesarea werd geboren. Multivariaat lineaire regressie analyse 
met correctie van confounders liet zien dat vaginale partus geassocieerd was met 
een betere neurologische funktieniveau na de geboorte in vergelijking met kin-
deren die gehaald waren met een sectio cesarea. Subgroep analyse liet een niet 
significante trend zien voor betere neurologisch funktioneel niveau in de groep 
die vaginaal geboren werd, waarbij de kinderen die in stuit werden geboren dit iets 
meer lieten zien dan de kinderen in hoofdligging. Er is geen evidence gevonden 
voor een betere neurologische outcome door een sectio cesarea.  
Hoofdstuk 4 is de beschrijving van een prospectieve studie waarbij een eenmalig 
vroeg neonataal EEG als mogelijke prognostische marker is onderzocht. In deze 
studie werden 31 kinderen, geboren tussen 2002 en 2007, geëvalueerd en vervolgd 
tot de leeftijd van 2,5 jaar om dan hun neurocognitieve ontwikkeling en lichame-
lijke beperkingen te bepalen. Alle neonatale EEG’s werden als normaal beoordeeld, 
echter 3 van de 31 kinderen liet een milde mentale ontwikkelingsachterstand zien 
en ernstige fysieke beperkingen. We concludeerden dat een enkel EEG van be-
perkte prognostische waarde is voor kinderen met een neuraalbuisdefect. Seriële 
EEG’s in combinatie met andere neurofysiologische onderzoeken, zoals MEPs en 
CMAPs, zijn wellicht van betere prognostische waarde. 
In aansluiting hierop, wordt in hoofdstuk 5 de prognostische waarde van neonatale 
CMAPs en MEPs onderzocht en vergeleken met klinisch neurologisch onderzoek 
bij kinderen met spina bifida. Van de oorspronkelijk 36 geïncludeerde pasgebore-
nen, waren er 29 die op de leeftijd van 2 jaar opnieuw geëvalueerd konden worden. 
MEPs van de quadriceps femoris, tibialis anterior en gastrocnemius spieren en 
CMAPs van de laatste twee genoemde spieren, voor de operatieve sluiting van 
het rugdefect, werden vastgelegd. Beter neurologisch functioneren op de leeftijd 
van 2 jaar,  gedefinieerd door classificatie middels Muscle Function Class (MFC) en 
loopfunktie status volgens Hoffer (community ambulant versus non-community 
ambulant), is geassocieerd met een grotere MEP en CMAP oppervlakte van de 
gastrocnemius en tibialis anterior spieren op de neonatale leeftijd. De oppervlak-
ten onder de neonatale CMAPs en lumbosacrale MEPs bleken groter in de groep 
mild aangedane kinderen dan in de groep ernstig aangedane kinderen. Echter de 
klinische parameters als sensibel en motorisch uitvalsniveaus bleken ook duidelijk 
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lager te liggen in de mild aangedane groep kinderen, waarbij het verschil evidenter 
leek dan voor de neurofysiologische parameters. Bij neonaten met spina bifida 
zijn MEPs en CMAPs van de twee genoemde spieren van beperkte prognostische 
waarde voor toekomstig neurologisch in vergelijking tot de klinische neurologische 
onderzoeksparameters. 
Naast neonaten werden ook schoolgaande kinderen in de leeftijd van 6 tot 14 jaar 
in ons onderzoek meegenomen, zoals beschreven in hoofdstuk 6. Hierin probeer-
den we de pathogenese van spina bifida verder te ontrafelen en de proportionele 
bijdrage van het centrale en het perifere motorische neuron aan de motorische 
functiestoornissen in de benen. Zenuwgeleidingsonderzoek en magneetstimula-
tieonderzoek werd verricht in een groep van 42 kinderen en 36 controle kinderen 
met vergelijkbare leeftijd. MEPs werden afgeleid aan de quadriceps femoris, tibialis 
anterior, gastrocnemius en de biceps brachii spieren, na transcraniële en lumbos-
acrale magneetstimulatie. CMAPs werden afgeleid na elektrische zenuwstimulatie 
verricht aan de tibialis anterior en gastrocnemius spieren. Motorische funktiestoor-
nis werd geclassificeerd aan de hand van spierkracht, Muscle Function Class volgens 
McDonald en loopfunktie volgens Hoffer. Op basis hiervan werden de kinderen als 
mild of ernstig aangedaan geclassificeerd. Ten aanzien van het functioneren van 
het perifere neuron zagen we dat ernstig aangedane kinderen met spina bifida dui-
delijke kleinere CMAP en MEP oppervlakten hadden dan controle kinderen, terwijl 
dit verschil bij de mild aangedane kinderen gering was. CMAP en MEP latenties 
verschilden niet tussen spina bifida kinderen en de controlegroep. Ten aanzien van 
het functioneren van het centrale neuron, zagen we bij kinderen met spina bifida 
kleinere transcraniële MEP oppervlaktes en langere centrale geleidingstijden dan 
bij de controle kinderen. De kleinste MEP oppervlakte en langste centrale gelei-
dingstijd werd gezien bij de meest ernstig aangedane spina bifida patiënt. Deze 
bevindingen suggereren dat het centraal motore neuron een belangrijkere rol 
speelt dan het klinisch neurologisch onderzoek wellicht doet vermoeden. 
In de discussie, beschreven in hoofdstuk 7, werden de resultaten van de onder-
zoeken die we verricht hebben in het licht geplaatst van de doelstelling die we 
hadden bij aanvang van het onderzoek. Een aantal methodologische kanttekenin-
gen werden geplaatst ten aanzien van de opzet van de studies en de metingen 
die we verricht hebben. Het complexe proces van counselling en het nemen van 
beslissingen door ouders over het al dan niet doorzetten van de zwangerschap en 
foetale chirurgie, kan ondersteund worden door huidige diagnostische technieken, 
maar het is nog steeds onmogelijk om een precieze individuele prognose af te 
geven voor ongeboren kinderen met een neuraalbuisdefect, met name ook gezien 
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de persoonlijke verschillen in opvatting over kwaliteit van leven, alleen al tussen 
toekomstige ouders en ook tussen ouders en patiënten. Prenataal vastgestelde 
waarden als bipariëtale diameter en hoofdomvang zijn niet van prognostische 
waarde, noch partusmodus. Foetale chirurgie zou wel eens de prognose van kinde-
ren met een spinaal dysrafisme in aanzienlijk mate kunnen verbeteren, echter daar 
tegenover staan aanzienlijke risico’s voor moeder en kind gezien de intra-uteriene 
procedure die plaats dient te vinden voor een amenorroeduur van 26 weken. 
Verbeterde beeldvorming prenataal om het effect van prenatale chirurgie te eva-
lueren is nodig en zal ons meer leren over de pathofysiologische processen die 
betrokken zijn bij een neuraalbuisdefect. Tenslotte, etiologische studies, primaire 
preventie en gecentraliseerde zorg voor kinderen met spinaal dysrafisme zijn van 
groot belang. 
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Dankwoord
In 2006 stapte ik vol enthousiasme op de “rijdende trein” van het Nijmeegs Inter-
disciplinair Spina Bifida Programma. Het werd een enerverende reis, waarin niet 
altijd over een gebaand pad werd gereden, maar waarin de trein hier en daar een 
zijspoor zou nemen om met enige tussenstops dan toch het beoogde eindpunt te 
halen. Het proefschrift is klaar!
Tijdens “mijn reis” heb ik vele mensen ontmoet, die een belangrijke bijdrage heb-
ben geleverd aan het tot stand komen van dit proefschrift. Dit dankwoord biedt 
mij de kans een aantal van deze mensen persoonlijk te bedanken. 
Allereerst gaat mijn dank uit naar alle kinderen en hun ouders die hebben mee-
gedaan aan het Nijmegen Interdisciplinair Spina Bifida Programma. Zonder jullie 
bereidheid, inzet en geduld, was dit proefschrift nooit tot stand gekomen. Van 
jullie heb ik zoveel meer geleerd dan in dit proefschrift staat beschreven.
Beste Professor Rotteveel, beste Jan, mijn beoogde promotor, in het bijzonder dank 
en waardering voor het feit dat je mij het vertrouwen hebt gegeven om mij te laten 
deelnemen aan dit bijzondere project, waarvan jij – samen met Reinier Mullaart 
- de belangrijkste initiator bent geweest. Wie had ooit voorzien dat na invoering 
van de 20 weken echo in 2007, het 1,5 jaar zou duren, voordat er weer een baby 
met spina bifida werd geboren in het Radboud? Ik vroeg me in die periode echt 
wel eens af of het de bedoeling was dat ik een geschiedenisboek ging schrijven, 
maar jij bleef optimistisch en geduldig. De avondoverleggen bij jou thuis, waarbij 
ook mijn “bondgenoten” Niels, Anja en Ignace met alle betrokken andere leden 
van het programma werden uitgenodigd, getuigden van inspiratie en gastvrijheid. 
Het werd altijd laat en we sloten deze overleggen af met een mooi glas wijn en 
inspiratie voor nog minstens tien proefschriften. Jouw enthousiasme en humor 
werkten voor mij inspirerend en motiverend. We hadden bij aanvang niet kunnen 
vermoeden dat je nog voor het einde van mijn fellowship met emeritaat zou gaan 
en welverdiend van je pensioen ging genieten met Els. Zelfs toen je te maken kreeg 
met gezondheidsproblemen, bleven de emails komen met het verzoek om toch 
nog een review te schrijven over de ontwikkelingen in de afgelopen 30 jaren op 
het gebied van spina bifida. Jouw enthousiasme en humor waren Rotteveliaans 
stimulerend. 
Beste Michèl, jij nam naast de rol van opleider ook de rol van promotor over van 
Jan. Dankjewel voor jouw motiverende inbreng en ondersteuning in de laatste 
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jaren van mijn promotie. Jouw originele ideeën en pragmatische adviezen en niet 
te vergeten jouw geduld, hebben er daadwerkelijk voor gezorgd dat het boekje 
afgeschreven is.  
Beste Nel, jij bent de continue factor geweest in mijn traject, veel dank voor het 
delen van jouw kennis over methologie en statistiek. De kritische, eerlijke feedback 
en tekstuele correcties van mijn artikelen waren bijzonder waardevol. Altijd kon ik 
bij jou terecht, op de universiteit en thuis in Groesbeek, dankjewel voor het ver-
trouwen in mij, dat heeft er uiteindelijk voor gezorgd dat dit boek af is geschreven. 
Je bent voor mij naast een bijzonder fijn mens ook echt professorabel!
Beste Jaco, dankjewel dat je mijn copromotor bent. Jij hebt als enige neurofysioloog 
in het bonte gezelschap een belangrijke rol gehad in het hele project. Met jouw 
ervaring en kennis heb jij me enthousiast gekregen voor het “MEP” en “CMAP” 
project. Urenlang en met een ijveren geduld heb je mij ook nog neonatale EEG’s 
leren beoordelen. Onvergetelijk was het uittesten van MEP bij ons zelf, alvorens 
woensdagmiddagen uren lang de kinderen hieraan bloot te stellen. Dankjewel voor 
het vertrouwen en jouw geduld. 
Mijn dank gaat ook uit naar de leden van de manuscriptcommissie, prof. dr. W.F.J. 
Feitz, prof. dr. F.P.H.A.  Vandenbussche en prof. dr. K.P.J. Braun. Dank allen voor 
jullie tijd en bereidheid voor de beoordeling van mijn manuscript. 
Onderzoek doe je nooit alleen. Beste Niels, collega promovendus van het eerste 
uur. Het pad was geplaveid, jij had het spina onderzoek op de kaart gezet en ik kon 
terecht met al mijn vragen bij jou. Ik had me geen beter maatje in het onderzoek 
kunnen voorstellen. Dank voor de plezierige samenwerking en jouw enthousiasme. 
Zonder jouw inbreng was dit boekje er nooit gekomen. Beste Anja, wat was het fijn 
om met jou als medeonderzoeker te mogen optrekken. Ik heb bewondering voor 
jouw talent en kennis. Dankjewel voor het delen van jouw ervaringen op het pad 
van een promovenda, jammergenoeg is Beek niet meer om de hoek!
Beste Corrie, Jolanda, Lilian, Charlotte en Miel. Dank voor de fijne samenwerking 
in het Radboud, met heel veel plezier denk ik daar aan terug, met een lach en een 
traan nam ik 5 jaar geleden afscheid van jullie. Corrie, het was fijn dat ik je kamerge-
nootje mocht zijn en dat jij jouw ervaringen op het gebied van promotieonderzoek 
met me deelde. Lilian, dank voor jouw vriendschap en niet aflatende interesse in 
mijn promotie, de borrels bij jou in de tuin met het zwembad zijn onvergetelijk en 
mis ik nog iedere zomer. Jolanda, jouw onuitputtelijke inzet en positieve instelling 
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waren een voorbeeld voor mij en geloof me, nu komt jouw boekje! Charlotte, wij 
begonnen samen in Nijmegen, waren collega’s en kamergenoten in Utrecht, maar 
jij verkoos toch Nijmegen en ging deze keer alleen. In de Nijmeegse periode mocht 
ik jouw paranimf zijn, dat was een hele eer, dank! En Miel, waarom kom je niet naar 
Utrecht, het was te leuk om met jou samen te werken!
Beste Collega’s kinderneurologen, inmiddels vijf jaar werk ik in het Utrechtse met 
veel plezier. Beste Kees, dank voor jouw betrokkenheid en vertrouwen in mij, jouw 
enorme kennis en passie voor het vak zijn een enorme inspiratie voor me. Jij hebt 
me op het goede spoor gezet voor het afronden van mijn manuscript en ik vind het 
een grote eer dat je in de manuscriptcommissie zitting wilde nemen. Ik verwacht 
de beste vraag bij mijn verdediging toch echt van jou. Floor, sinds kort mag ik een 
kamer met je delen, ik ben vol bewondering voor je multi talent en drive, fijn dat ik 
met jou mag samenwerken. Frédérique, master of Science, dank voor je positieve 
inbreng, ik kan altijd bij jou terecht en ben trots op je, de enige in onze groep met 
een unieke titel achter haar naam! Karin, kamergenoot van het eerste uur, dank 
voor je luisterend oor, die doppio’s en lattes houden we erin! Judith, toegewijde 
gedreven collega, fijn dat je bij ons in Utrecht bent komen werken. Janneke, wel-
kom in Utrecht, fijn dat je je bij ons in de groep hebt gevoegd! Hélène, dank voor je 
oprechte belangstelling en jouw hulp bij het voltooien van mijn manuscript. 
Beste Prof. Rinkel, Gabriel, dank voor het duwtje in de rug, het boek hoeft niet dik 
te zijn maar wel af.
Beste Collega’s van de spina bifida werkgroep, dank voor de fijne samenwerking, 
zowel in het Radboud als momenteel in het WKZ. De kinderen met spina bifida 
verdienen onze toegewijde zorg.  
Beste Ludo, dank voor je vertrouwen en geduld. Nu dit boek af is, kunnen we het 
door jou ingezette plan voor Spieren voor Spierenkindercentrum verder verwe-
zenlijken.   
Om een promotie succesvol af te ronden was de steun vanuit lieve vrienden en het 
thuisfront onontbeerlijk. 
Dank lieve vrienden -ik kan jullie niet allemaal persoonlijk gaan noemen- voor jullie 
interesse in mijn promotie en de bemoedigende woorden! 
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Lieve Judith, ik weet niet beter dan dat jij er bent als vriendin, dankjewel voor jouw 
loyaliteit en vriendschap, heel fijn dat jij nu mijn paranimf bent!
Lieve Anke, zus en nu mijn paranimf, fijn dat je er altijd bent voor mij, samen met 
Erik, Nienke, Djoeke en Bente! 
Lieve Ed en Dineke, schoonouders, dank voor jullie interesse en steun voor het 
thuisfront, fijn dat we altijd bij jullie terecht kunnen.  
Lieve Leanne, dank voor je belangstelling voor mijn proefschrift, het is goed om 
vooruit te kijken, nu kunnen we weer vaker afspreken met jou, Linde en Else!
Lieve papa en mama, jullie hebben me laten worden wie ik nu ben, dank voor jullie 
onvoorwaardelijke liefde en steun in raad en daad. Jullie hebben me het vertrouwen 
gegeven en de vrijheid om te gaan doen wat ik echt graag wil. 
Lieve Willem-Jan, Annemijn en Charlotte, het leven is elke dag een feestje samen 
met jullie, het boekje is nu af, mama mag niet meer zoveel achter de laptop, het is 
heerlijk om samen met jullie elke dag te vieren!
Lieve Hubert, mijn allerliefste steun en toeverlaat, dank voor je geduld en onvoor-
waardelijke liefde. Samen is de wereld zoveel mooier!
Inge
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Curriculum Vitae
Inge Cuppen was born in Maasdriel, the Netherlands, on the 15th of June, 1975. In 
1993, she graduated from high school (gymnasium, Zwijsen College Veghel) and 
started medical school at the University of Utrecht. During high school she already 
became interested in paediatrics, in particular pediatric neurology. She suspended 
her medical school training from 1997-1998 to spend six months abroad, work-
ing for a research lab performing electron microscopy and Western Blotting for 
patients with Batten Disease (Neuronal Ceroid Lipofuscinosis), in Children’s Medi-
cal Hospital Dallas, Texas, under the supervision of Professor M.J. Bennett. During 
her medical internships, she choose to work for three months (August 2000) on 
the Pediatric Neurology Department of the University Medical Centre of Utrecht, 
under the supervision of Professor Onno van Nieuwenhuizen. After completing 
her medical school, she started in the end of 2000 as a resident-not-in-training 
in Pediatrics at the Jeroen Bosch Medical Centre in Den Bosch. In January 2002 
she started her residency in Pediatrics at the Radboud University Medical Centre. 
In the summer of 2006 she finished her training in paediatrics and started with a 
fellowship in Pediatric Neurology at the Department of Pediatric Neurology of the 
Radboud University Medical Centre, under the successive supervision of Profes-
sor Jan Rotteveel and Professor Michèl Willemsen. She combined the fellowship 
with this PhD-project.  After completing her fellowship in May 2012, she started 
working as a pediatric neurologist at the Department of Pediatric Neurology of 
the University Medical Centre of Utrecht. Since 2000, Inge is living together with 
Hubert Sasker. They have a son (2007) and two daughters (2009, 2011) and 
moved to Zeist in 2014. 
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Uitnodiging
Op woensdag 20 september 2017, 
om 14.30uur precies,  
zal ik mijn proefschrift in het 
openbaar verdedigen in de Aula 
van de Radboud Universiteit 
Nijmegen, Comeniuslaan 2 te 
Nijmegen. 
Direkt na afloop van de 
promotie bent u samen met 
uw partner van harte 
uitgenodigd voor de 
receptie overgaand in een 
walking diner. 
Lokatie
Restaurant BEAU
Driehuizerweg 285
6525 PL Nijmegen. 
www.restaurant-beau.nl
Tot dan!
Wilt u svp vóór 15 september 2017 
laten weten of u komt?
Paranimfen
Anke Cuppen | 06-18436448
Judith Wieland | 06-34149130
Inge Cuppen
Erasmuslaan 49
3707 ZB Zeist
06-19218384
i.cuppen@umcutrecht.nl
cadeautip: 
